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CLINICAL AND FUNCTIONAL ASSESSMENT FOLLOWING AUTOLOGOUS 
CHONDROCYTE IMPLANTATION TO THE KNEE:  
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Autologous chondrocyte implantation (ACI) is a cell based therapy for the 
treatment of articular cartilage defects.  Numerous studies have reported outcomes 
following ACI using a variety of patient reported outcomes (PROs), but no clear 
recommendations exist regarding which PRO is the most responsive to changes following 
ACI.  Few studies have documented changes in performance based assessments (PBAs) 
following ACI.  Response shift theory proposes that residual changes in self-report 
measures occur over time.  Failing to account for response shift may result in over or 
under reporting of outcomes from which clinical decisions are made.  The purposes of this 
dissertation were 1) review the literature concerning ACI outcomes to determine the 
responsiveness of PROs to changes in self-reported function following ACI, 2) evaluate 
the reliability of PBAs among ACI patients, 3) develop a descriptive timeline for the 
return of function 1 year following ACI using both PROs and PBAs, and 4) utilize PROs 
and PBAs to evaluate patients undergoing ACI for evidence of response shift.   
All PRO and PBA measures were collected preoperatively and 3, 6, and 12 
months postoperatively.  A retrospective then-test PRO evaluation of function prior to 
surgery was completed at 6 and 12 months.  Response shift was calculated by subtracting 
the original pre-test score from the then-test score.   
 A systematic review and meta-analyses of existing ACI outcome studies resulted 
in the recommendation of the International Knee Documentation Committee Subjective 
Knee Form (IKDC) and Lysholm Knee Scale as highly responsive PROs among ACI 
patients of varying activity levels.  Despite significant increases in PRO scores as early as 
6 months following ACI, improvement in PBAs at 12 months following ACI were limited 
to stride length, walking speed, and step-up force.  Finally, no evidence of a group level 
effect for response shift was observed.  These results support the validity of traditional 
pre-test/post-test research designs with no need to account for response shift when 
evaluating treatment effects of ACI on the group level.  However, the Western Ontario
and McMasters University Osteoarthritis Index (WOMAC) did show evidence of a 
measurable response shift on a patient by patient basis. 
KEYWORDS:  Autologous Transplantation, Cartilage, Chondral Defect, Force Plate, 
Outcomes Assessment 
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CHAPTER 1: INTRODUCTION AND SYSTEMATIC REVIEW AND META-
ANALYSIS OF PATIENT REPORTED OUTCOME INSTRUMENTS FOLLOWING 
AUTOLOGOUS CHONDROCYTE IMPLANTATION 
Articular cartilage defects of the knee are a complex and challenging pathology 
with limited options for treatment and clinical management.    The poor healing of these 
defects has been documented for over 200 years,
75
 and when left untreated can progress to 
osteoarthritis.
99
  Defects have been observed to occur in 63% of all knee arthroscopies,
39
 
and may be associated with trauma or be idiopathic in nature.  One report observed 
defects present in 16 to 46% of ACL reconstructions.
30
  If not treated appropriately 
defects to the articular cartilage can become increasingly painful and disabling.  This is 
particularly true for lesions of the knee where biomechanical stresses result in both shear 
and compressive forces during normal activities of daily living.    
Treatment of articular cartilage injuries represents a complex and challenging 
problem for both orthopedic surgeons and rehabilitation specialists. Treatment options for 
articular cartilage defects can range from simple debridement to marrow stimulating 
techniques or more complex auto- and allograft treatments.  One emerging form of 
treatment is cell based therapies.  These treatments are based on the implantation of 
chondrocytes into the symptomatic defect.  The use of autologous chondrocyte 
implantation/transplantation (ACI or ACT) in a human population was first reported in 
1994.
28
  The ACI procedure involves a two step surgical process.  During the first surgery 
a biopsy of healthy chondrocytes is obtained from a low weight bearing portion of the 
knee such as the intracondylar notch.  These cells are then cultured and expanded in a 
laboratory and then transplanted into the defect in a second surgery.  The original 
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procedure called for cells to be transplanted under a periosteom flap harvested from the 
patient during the second surgery.
28
  The procedure has since been modified to commonly 
use a porcine type I/III collagen membrane to cover the defect in place of the periosteal 
flap (ACI-C).
21, 59, 92
  In some regions the seeding of chondrocytes on a porcine type I/III 
collagen bilayer matrix (MACI) prior to implantation has also been introduced into 
practice as the third generation of the ACI procedure.
13, 35
 
PURPOSE 
 For each generation of ACI introduced, numerous reports of treatment outcomes 
have been presented.  However these outcomes have focused primarily on patient 
reported outcomes (PROs) and disease oriented outcomes such as magnetic resonance 
imaging (MRI) or tissue biopsy.  Very few investigators have documented ACI outcomes 
using performance based assessments (PBAs).  PBAs provide a direct, objective measure 
of patient function that can be combined with PROs to form a full picture of clinical 
outcomes following treatment without regard for the biologic outcome that is assessed by 
MRI or tissue biopsy.  This study was an investigation of clinical and functional outcomes 
following ACI to the knee and the methodology for documenting those outcomes.  The 
primary purposes of this dissertation were the following: 
1. To systematically review and evaluate via meta-analysis the responsiveness of 
common instruments used to measure PROs following ACI at varying time points.  
Hypothesis:  All instruments will demonstrate improved self-reported function and 
health related quality of life following ACI with the simplest instruments showing the 
greatest treatment effect. 
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2. To determine among articular cartilage patients the reliability of the following 
NeuroCom Balance Master
®
 long force plate assessments:  Walk Across, Weight 
Bearing Squat, Unilateral Stance, Sit-to-Stand, Step Up/Over, and Forward Lunge 
tests.  Hypotheses:  The reliability of all measures of time, distance, and force will 
demonstrate acceptable ICC values>0.75.  There will be poor reliability of measures 
of sway and balance with ICC values <0.75. 
3. To document the clinical outcomes of ACI patients over one year following surgery 
utilizing both patient reported outcomes (PROs) and performance based assessments 
(PBAs), and to examine the relationship between PROs and PBAs.  Hypotheses: All 
PROs and PBAs will demonstrate an initial decrease in function at the three month 
time point.  There will be improved function at 6 months and improvements from 
baseline at the 12 month time point based on PRO and PBA evaluations.    
4. To determine if patients undergoing ACI experience a response shift between 
preoperative assessment and evaluation at 6 and 12 months postoperative.  
Hypotheses: There will be evidence of a response shift as assessed via PROs.  
Further evidence of this response shift will be supported by changes in the 
relationship between PROs and PBAs over time.  
OVERVIEW 
This dissertation is organized according to the following:  Chapter 1 consists of a 
systematic review of the use of PROs to document patient outcomes following ACI.  This 
chapter will provide a historical context of the use of PROs and treatment outcomes 
following ACI.  Chapter 2 presents the reliability of a series of PBAs utilizing the 
NeuroCom Balance Master
®
 long force plate in an ACI patient population.  Reliability 
was evaluated both preoperatively and 12 months following ACI to determine the 
4 
 
reliability of the chosen measures across time points.  Chapter 3 reports PRO and PBA 
outcomes prior to ACI and at 3 months, 6 months and 12 months following ACI.  This 
information will provide a time line for recovery and return of function following ACI. 
Chapter 4 investigates the evidence of a response shift phenomenon influencing PROs 
following ACI.  The relationship between PROs and PBAs across time will be examined 
in an attempt to validate the occurrence of a response shift.   Chapter 5 will summarize the 
results of all portions of this dissertation and interpret these finding for future research 
and clinical application. 
OPERATIONAL DEFINITIONS 
Autologous Chondrocyte Implantation (ACI): 
Two stage, cell based surgical therapy for the treatment of articular cartilage 
defects.  Stage one involves the biopsying of healthy articular cartilage from a non-or 
low-weight bearing portion of the knee.  This cartilage is then cultured and expanded, and 
these chondrocytes are transplanted into the defect during a second surgery. 
Patient Reported Outcome (PRO): 
 Self report questionnaires or instruments intended to document the patients’ 
perspective of their level of function and/or health related quality of life. 
Performance Based Assessment (PBA): 
Form of an objective evaluation requiring physical or mental function, ability, or 
competence of a task that is typically measured in a quantifiable variable such as time, 
speed, force, distance, or errors. 
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Response Shift: 
A residual change in perception that occurs over time and can affect PROs based on 
the patient’s internal frame of reference pre- or post-intervention. These changes are due 
to recalibration, reconceptualization, and reprioritization of internal standards and 
references utilized for self-appraisal. 
ASSUMPTIONS 
The primary assumptions of this dissertation were the following;  
1. Subjects provide honest answers and best effort when completing PROs 
and PBAs. 
2. Subjects clearly understood and followed instructions for both PROs and 
PBAs. 
3. Changes in PBAs were related to changes in knee health and not other, 
unknown, unreported, underlying conditions. 
4. All patients were compliant with activity restrictions and rehabilitation 
protocols. 
DELIMITATIONS 
1. For the meta-analysis portion of this dissertation, only those studies presenting 
statistics from which effect sizes could be calculated were be included. 
2. For the meta-analysis portion of this dissertation only those studies reporting 
PROs using the Medical Outcomes Study 36-Item Short Form Health Survey 
Physical Component Scale (SF-36 PCS), the International Knee 
Documentation Committee Subjective Knee Form (IKDC), the Lysholm Knee 
Scale (Lysholm), the modified Cincinnati Knee Rating System (MCKRS), the 
6 
 
Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), 
or the Knee Injury and Osteoarthritis Outcome Score (KOOS) were included 
3. All surgeries were performed by a single surgeon and all patients were 
recruited from a single practice. 
4. All physical therapy was completed in individual outpatient clinical settings 
and was not directly supervised or controlled. 
5. No direct measures of cartilage healing such as MRI or tissue biopsy were 
utilized in this study. 
6. All patients undergoing ACI regardless of defect locations or the occurrence of 
realignment procedures have been included 
7. Previous injury or surgery was not controlled for. 
8. The “then-test” method was used to test for response shift among ACI 
patients, and this method may be susceptible to recall bias. 
LIMITATIONS 
1. A number of patients (n=5) were lost to follow-up during the course of this 
study.  Despite multiple attempts to contact these patients complete data for 
these patients could not be obtained and is therefore missing from the 
presented results. 
2. A number of patients (n=6) were declared clinical failures during the course of 
this study and either underwent surgical revision prior to study completion or 
performance testing was contraindicated by the treating physician.  When 
possible data from these patients were included in the results of this study.  
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SYSTEMATIC REVIEW AND META-ANALYSIS OF PATIENT REPORTED 
OUTCOME INSTRUMENTS FOLLOWING AUTOLOGOUS CHONDROCYTE 
IMPLANTATION 
 
Introduction 
 The limited ability of articular cartilage to heal on its own has been a topic of 
discussion for over 200 years.
75
  The treatment and management of articular cartilage 
damage can be particularly challenging in the knee joint where such defects have been 
frequently observed during arthroscopic surgery. 
30, 39, 68, 182
    Restorative and reparative 
treatment of these defects, whether they penetrate to the subchondral bone (osteochondral 
lesions) or remain limited to the cartilage surface (chondral lesions), is highly desirable to 
prevent the progression of osteoarthritis.
99
   
Autologous Chondrocyte Implantation 
Over the last three decades, approaches to treating chondral defects have shifted 
towards cell based therapies.  These therapies have focused predominantly on the 
implantation of autologous chondrocytes directly into pathologic defects.  The first 
published reports of human outcomes following autologous chondrocyte implantation 
were presented in 1994.
28
  As originally described, autologous chondrocyte implantation/ 
transplantation (ACI or ACT) is a two stage treatment where a cartilage biopsy is taken in 
one surgery and during a later surgery cultured chondrocytes are implanted into the 
defect.
28
  Due to complications with graft hypertrophy considered to be linked to the use 
of the periosteal flap used to cover the defect and to reduce concomitant trauma, the 
procedure has since been modified to commonly use a porcine type I/III collagen 
membrane to cover the defect in place of the periosteal flap (ACI-C).
21, 59, 92
  In efforts to 
further advance the procedure, a third generation of ACI involves the seeding of 
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chondrocytes on a porcine type I/III collagen bilayer matrix (MACI) prior to 
implantation.
13, 35
  Finally, the 4
th
 generation of ACI to become commercially available is 
characterized chondrocyte implantation (CCI).
152
   This method involves the use of a gene 
marker profile to determine the cartilage forming potential of cells to selectively choose 
cells for expansion and implantation.   
Treatment Evaluation 
As new methods for treating cartilage are developed it is necessary to evaluate 
these treatments to determine their effectiveness.  While second look arthroscopies with 
cartilage biopsies provide the most diagnostic method of evaluating cartilage repair, they 
are not always feasible or ethical to perform.  In addition, biopsies allow for the 
assessment of the histological tissue repair, but they cannot be used to evaluate patient 
oriented outcomes such as pain and function.  To evaluate patient oriented outcomes 
researchers and clinicians have relied on patient reported outcome instruments (PROs).  
Numerous PROs have been developed to address outcomes associated with a specific 
body part or region, a specific disease, or health related quality of life as a whole.  
Numerous PROs have been utilized to document patient response to cartilage repair.  
While the widespread use of PROs is beneficial for documenting treatment outcomes, the 
wide variety in the PROs makes comparison across studies and instruments difficult.  
Ideally, a standard instrument or battery of instruments would be more advantageous for 
reliably and validly assessing patient response to treatment.   
Some of the most commonly used PROs to evaluate articular cartilage repair 
outcomes include the Medical Outcomes Study 36-Item Short Form Health Survey (SF-
36),
105, 106, 179
  the International Knee Documentation Committee Subjective Knee Form 
(IKDC),
77
 the Lysholm Knee Scale (Lysholm),
96, 168
  the modified Cincinnati Knee Rating 
9 
 
System (MCKRS),
31
 the Western Ontario and McMaster Universities Osteoarthritis Index 
(WOMAC),
18, 19
 and the Knee Injury and Osteoarthritis Outcome Score (KOOS)
148
.  
While all of these instruments have been widely used to evaluate ACI treatment efficacy, 
there is no clear standard regarding which outcome instrument is ideal for evaluating 
treatment progress or overall treatment effect following ACI.  PRO responsiveness is the 
evaluation of change in the instrument score over time in response to treatment.
85
  The 
reported responsiveness in self-reported function following ACI has not been compared 
among instruments.  Identification of the most responsive instrument for an ACI 
population will provide clinicians and researchers with a disease specific tool to compare 
treatment effects between therapies. 
The purpose of this study is to systematically review and summarize the scientific 
literature in regards to changes in PRO scores after ACI treatment.  For analysis, we have 
selected the commonly utilized outcome instruments in cartilage repair studies including 
the IKDC, Lysholm, MCKRS, KOOS, WOMAC, SF-36.  The outcome of interest for this 
systematic review is PRO responsiveness following ACI treatment.  Meta-analyses of 
PRO score changes will be compared among instruments to determine the responsiveness 
of each instrument at specified postoperative time points.  Secondarily, a within-
instrument comparison was performed to evaluate the responsiveness of individual PROs 
at specified time points to determine if the instrument is more responsive to changes in 
self-reported knee function at different time points during recovery.  A better 
understanding of the responsiveness of each instrument will allow for improved selection 
of outcome instruments in future cartilage research. 
 
10 
 
Methods 
Evidence Acquisition 
Search Strategy 
In February 2010 investigators conducted a systematic search of the literature 
using CINAHL (from 1981), Medline (from 1966), and SPORTDiscus (from 1800) to 
identify reports of PROs following autologous chondrocyte implantation/ transplantation.  
Search terms used were autologous, chondrocyte, outcome, and knee.  All abstracts were 
then reviewed for study inclusion/exclusion.  In the event the abstract did not provide 
sufficient information to determine study eligibility the full manuscript was reviewed.  
Additionally the reference lists of all included studies were reviewed to identify other 
potentially eligible studies (Figure 1.1.). 
Selection Criteria 
All studies were required to meet the following inclusion criteria; 1) publication in 
the English language, 2) investigations with human participants, 3) prospective evaluation 
of patient outcomes following cell based treatment of articular cartilage defects with some 
form of cultured autologous chondrocytes, 4) utilization of at least one of the following 
PRO instruments: IKDC, Lysholm Knee Scale, MCKRS as described by Browne et al.
31
, 
KOOS, WOMAC, or SF-36 Physical Component Scale (SF-36 PCS) preoperatively and 
at a minimum of 1 postoperative time point, and 5) reporting of statistics from which 
effect sizes and 95% confidence intervals could be calculated.  These included sample 
sizes and any of the following: preoperative and postoperative means and standard 
deviations, exact p-values for identified parametric statistical tests, preoperative and 
postoperative means and standard errors, or mean change scores and standard deviations.  
11 
 
Figure 1.1 Search Process and Study Selection Results for Patient Reported 
Outcomes Following Autologous Chondrocyte Implantation 
 
Assessment of Methodological Quality and Level of Evidence 
 The quality of all included studies was assessed using the Coleman Methodology 
Score modified by Kon-Verdonk.
37, 87
  This assessment tool was specifically adapted to 
evaluate the quality of cartilage repair studies and includes 11 parameters on a 100 point 
scale (100 = highest quality): study sample size (10 points possible for >60 defects 
evaluated), average follow-up period (10 points possible for a mean follow-up >60 
Searched: 
Cumulative Index to Nursing and Allied Health Literature 
(CINAHL), Medline, and Sports Discus.
Keywords: autologous, chondrocyte, outcome, and knee
216 studies 
identified.
73 studies included 
based on abstract 
and title
40 studies excluded due to 
insufficient data reporting
33 studies included 
after full 
manuscript review
9 additional studies identified 
from review of reference lists
42 studies 
selected for 
final inclusion
143 studies excluded following 
abstract and title review
12 
 
months), number of concomitant surgical procedures performed (10 points possible if 
only a single isolated surgical procedure was reported on), study design (15 points 
possible for a randomized controlled trial), description of the surgical procedure (up to 5 
points for adequate, detailed description), description of postoperative rehabilitation (up 
to 5 points if well described), the inclusion of MRI outcome (10 points possible if results 
reported for >80% of patients), the inclusion of histological outcome (10 points possible if 
reported for >50% of patients), outcome criteria (5 points if clearly defined with reported 
good reliability and sensitivity), procedure for assessing clinical outcomes (up to 7 points 
for patient recruitment, investigator independent from surgeon, and independent patient 
completion of outcomes), and description of subject selection process (up to 8 points for 
clear and unbiased selection criteria and >80% recruitment rate).
87
   
Level of evidence was evaluated based on criteria from the Centre for Evidence 
Based Medicine
4
 and was used to characterize the quality, quantity, and consistency of 
the included studies.   Using this taxonomy, the quality of the evidence for the included 
studies was determined and a grade of recommendation was generated for the use of each 
PRO as a measure of ACI treatment effect.  Consistent level 1 studies yields a grade of 
A.
4
 A grade of B results from consistent level 2 or 3 studies or extrapolations from level 1 
studies.
4
  A grade of C is given for level 4 studies or extrapolations form level 2 or 3 
studies, and a grade of D is the result of level 5 evidence or inconsistent or inconclusive 
evidence regardless of the level of evidence.
4
 
Methodological quality assessment and the rating of the level of evidence were 
assessed independently by two investigators.  Discrepancies in scoring were discussed 
until a consensus score was agreed upon. 
13 
 
Data Extraction 
The primary outcome variables of interest were scores on 6 specified PROs: the 
IKDC, Lysholm Knee Scale, MCKRS, KOOS, WOMAC, and SF-36 PCS.  From each 
study all data that could be used for the calculating of effect sizes for PROs was extracted.   
Medical Outcomes Study 36-Item Short Form Health Survey Physical Component Score 
(SF-36 PCS): 
The entire SF-36 is frequently used as a global measure of health-related quality 
of life (HRQOL) in all patient populations.
64
   It is also commonly used as a criterion 
reference scale in many studies validating region and disease specific scales.
25, 26, 78, 85, 103, 
136, 147, 148
  Traditional scoring of the SF-36 involves 8 individual sub-scales
1
 but the SF-36 
has also been reported as 2 summary physical and mental scores or as a single score.
64
  
Test-retest reliability for SF-36 PCS has a reported ICC value of 0.92 to 0.95 among 
former articular cartilage patients (minimum 5 years post-ACI surgery).
58
  SF-36 PCS 
evaluates physical knee function across a variety of activities ranging from activities of 
daily living such as dressing and bathing to general questions about more demanding 
activities such as climbing stairs, walking more than a mile or participating in strenuous 
sports.  However, unlike the IKDC the SF-36 does not address specific joint functions 
such as landing, pivoting, or starting and stopping.  The SF-36 uses a normative based 
scoring system under which 50 represents an average score based on historical data.
1
  
Lysholm Knee Scale (Lysholm):   
The Lysholm scale contains 8 items that are scored as a single scale. 
96, 168
  For 
overall score, measures of internal reliability are consistent across authors ranging from 
0.65 to 0.73.
25, 26, 85, 168
  The Lysholm has been documented as having high test-retest 
reliability across a variety of knee patients including those undergoing microfracture for 
14 
 
treatment of articular cartilage defects
85
 with ICC values ranging from 0.89  to 97.
25, 26, 103, 
104, 136, 168
 
85
  Specifically, this scale evaluates knee symptoms – locking, stability, pain , 
and swelling – in addition to function during common low to moderate activities 
including walking, stair climbing and squatting.  Unlike the IKDC, KOOS, or SF-36 PCS 
no part of the Lysholm addresses sport participation or knee function during sporting 
activities. 
Modified Cincinnati Knee Rating System (MCKRS): 
The Cincinnati Knee Rating System in its full form has undergone multiple 
revisions and been presented in various modified formats since its introduction.
124-128
  
While the original scale is more complex, a modified version of the Cincinnati Knee 
Rating System that has been commonly used to evaluate ACI patients consists of one to 
three simple questions asking patients to rate their perception of their knee, their pain, and 
their swelling on a 0 (severe) to 10 (normal knee/No problems) scale with descriptive 
references provided for all even values.
31
 Because of the variation in Modified Cincinnati 
Knee Rating Systems reported in the literature only the MCKRS presented by Browne et 
al. was included in this review.
31
  To avoid inappropriate comparison of various versions 
of MCKRS, studies that were included were required to either publish the scale directly in 
the manuscript or provide a clear reference for its use.  Reliability for a version of the 
MCKRS has been evaluated in a population of former ACI patients where an ICC of 0.80 
to 0.91 was observed; however, caution should be used in interpreting this value as no 
reference was provided for what version of the MCKRS was evaluated.
58
   
 
 
15 
 
Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC): 
The WOMAC is a disease specific instrument evaluating pain, stiffness, and 
function typically in an osteoarthritic (OA) patient population.
18, 19
  This instrument may 
be presented in a visual analogue scale format or as Likert type scales.  A total score can 
be calculated by combining the pain, stiffness, and function subscales. An ideal score is 
zero, representing no disability, while the worst possible total score is 96 points (20 points 
pain, 8 points stiffness, 68 points function).  Test-retest reliability among former ACI 
patients for the individual subscales and for the total WOMAC score has been reported to 
have ICC values ranging from 0.75 to 0.93.
58
 While all cartilage repair patients do not 
have OA, most experience the joint swelling, crepitus, pain, and loss of function that 
typically characterizes OA and which the WOMAC evaluates.  This instrument does not 
require high level strenuous physical activity to achieve maximum scores.  By focusing 
on evaluating low to moderate demand activities of daily living (sitting, bathing, rising 
from sitting, household chores, etc.), the WOMAC may be an appropriate PRO among 
patients who do not desire to return to high level activity.   
International Knee Documentation Committee Subjective Knee Form (IKDC):  
The IKDC is a 20 item instrument that was developed by reviewing existing 
patient report instruments to create a consensus form that could be used to document 
changes in HRQOL over time for patients with various knee problems.
76
  The IKDC is 
typically scored as a single scale instrument representing symptoms, activity, and sports 
function as a single construct.
77
   Test-retest reliability has been observed among former 
ACI patients (minimum of 5 years post ACI) with ICC values ranging from 0.91 to 0.93.
58
  
Of the scores included in this review the IKDC evaluates the highest level of function 
with questions regarding jumping, pivoting, squatting, and stopping and starting quickly. 
16 
 
Knee Injury and Osteoarthritis Outcome Score (KOOS): 
The KOOS consists of 42 questions with 5 item Likert-type response choices 
covering the domains of activities of daily living (17 questions), symptoms (7 questions), 
pain (9 questions), knee related quality of life (4 questions), and sports and recreation (5 
questions).
148
   The KOOS was originally developed for use with patients with anterior 
cruciate ligament injuries, meniscus injuries, or post-traumatic osteoarthritis and contains 
all of the questions included in the WOMAC.
148
  Each subscale is scored out of 100 
possible points with 100 representing no knee problems.  A total KOOS score is also 
occasionally reported out of a possible 100 points.  In its initial reliability evaluation 
among knee patients ICC values ranged from 0.75 to 0.93 across all subscales.
148
  The 
Dutch version of the KOOS, yielded ICC values of 0.87 to 0.95 for individual subscales 
and 0.97 for the overall KOOS among articular cartilage patients.
17
  The existence of 
multiple subscales within the KOOS allows for the evaluation of varying levels of 
function from activities of daily living to sports activities within a single outcomes 
instrument.  While the multiple subscales can be cumbersome to compare across groups, 
unlike the IKDC or the Lysholm they allow the identification of treatment effects in 
individual domains relating to pain, symptoms, function, and quality of life. 
Data Analysis 
For each outcome score, individual pre- to postoperative effect sizes were 
calculated using bias-corrected Hedge’s g with 95% confidence intervals (CI).  Separate 
meta-analyses were then performed to provide a summary response for each PRO at 
individual specified time points. For the purposes of analysis, follow-up time points were 
grouped into 4 categories, Time Point I (less than 1 year); Time Point II (1 year to less 
than 2 years); Time Point III (2 years to less than 4 years); and Time Point IV (4 years or 
17 
 
greater).  For each meta-analysis, a random effects model was employed.  In comparison 
to the fixed effect model, the random effects model provides a more conservative 
summary effect by estimating the mean effect size and confidence interval for the 
distribution of all relevant true effect sizes.
24
  We chose this model specifically because 
the effect sizes and confidence intervals analyzed in each meta-analysis were generated 
from independent studies that utilized similar, but nonuniform methods.
24
   
Individual measures across the multiple studies were pooled from the included 
studies using a bias-corrected Hedges’ g
24
 and 95% confidence intervals to examine the 
magnitude and precision of the difference between pre- and postoperative PRO scores.  
Most studies made multiple comparisons across separate time points.  Each comparison 
was treated independently within the statistical analyses of the measurement parameters.  
All effect sizes, 95%CIs, and Z-distribution p-values were calculated in Comprehensive 
Meta Analysis (Comprehensive Meta Analysis Version 2.0, Biostat, Englewood, NJ).  It 
is important to note that Hedges’ g is a standardized effect, which creates a unitless 
measure which is also corrected to represent an effect that exists on a parametric 
distribution.  Across the parameters, the standardized effects were pooled for each PRO 
using meta-analyses conducted in Comprehensive Meta Analysis.  A positive effect size 
indicated improvement in postoperative PRO score compared to preoperative score.  
Effect sizes for which confidence intervals did not overlap were considered to be 
significantly different.  To interpret the strength of the effect sizes, Cohen’s guidelines 
were used.
36
  Values were interpreted as small if they were between 0.20 and 0.49, 
moderate if between 0.50 and 0.79, and values of more than 0.80 were interpreted as 
large.
36
  
18 
 
Assessment of Publication Bias 
 To assess the likelihood of publication bias, a funnel plot of all measures included 
in the study was generated by plotting standard error against Hedge’s g effect size for 
each included study.  To assess the robustness of the observed overall effects of the 
variations in study design on PRO score, Orwin’s Fail-Safe N test was employed.
132
  For 
this test a Hedge’s g effect size of 0.1 was assumed for all missing studies, or studies 
excluded due to publication bias, and the number of missing studies necessary to reduce 
the overall mean effect size for each instrument to a 0.4 was calculated.  These values of 
were chosen to determine how many studies demonstrating a negligible effect (0.1) would 
be needed to be added to the existing sample of studies to result in a small (0.4) overall 
mean effect. 
 
Results 
Study Selection 
 The initial literature search yielded 216 results.  Application of inclusion and 
exclusion critera resulted in the inclusion of 42 articles.
14, 16, 23, 27, 31, 41, 42, 44, 48, 50, 54, 55, 65-67, 
69, 84, 86, 89, 98, 100, 107, 108, 112, 115, 118, 121-123, 129, 133, 135, 137, 146, 149-152, 158, 171, 185, 186
  Study 
selection and inclusion is depicted in Figure 1.1.  Those studies included in the study are 
summarized seen in Table 1.1.  A total of 2016 patients with a mean age of approximately 
34.5 yrs are reported on in the included studies.  Overall, 16 studies reported outcomes 
using the IKDC, 11 studies used the KOOS (2 reporting only total KOOS scores), 18 
studies reported values for the Lysholm, 12 studies used the MCKRS, 9 studies reported 
SF-36 PCS values, and only 2 studies meeting the inclusion criteria utilized the WOMAC. 
19 
 
Methodology Scoring and Level of Evidence 
 The mean modified Coleman Methodology Score for all included articles was 50.9 
± 9.2, with a range of 35 to 68.  Overall, the least reported parameters were of inclusion of 
MRI outcomes, inclusion of histological outcomes, and description of subject selection 
process.  CEBM level of evidence was 2b for 38 articles and 1b for 4 articles included.  
Based on the consistent reporting of level 2 studies a grade B recommendation was made 
for the use of the IKDC, KOOS, Lysholm, MCKRS, SF-36 PCS, and WOMAC as 
outcome measures following ACI.
4
 
Assessment of Publication Bias 
 A funnel plot of all measures included in the meta-analysis portion of this study 
can be seen in Figure 1.2.  The funnel plot displays an asymmetrical distribution of 
studies with a disproportionate number of studies above the mean effect size at the bottom 
of the funnel.  These results suggest a slight publication bias towards studies 
demonstrating large treatment effects, particularly for studies with smaller sample sizes.  
However, the results of the Orwin’s Fail Safe N test (Table 1.2) demonstrate that an 
additional 14 (SF-36 PCS) to 196 (KOOS) studies with a trivial effect size of 0.10 are 
necessary to reduce the mean effect size for any of the PROs to a weak value of 0.40, 
meaning that the observed overall effects are very robust and not likely to be artificially 
influenced by this potential publication bias. 
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Figure 1.2. Funnel Plot to Evaluate Publication Bias
 
Figure 1.2 The observed funnel plot suggests a slight publication bias towards studies 
demonstrating larger effect sizes, with an asymmetrical distribution of studies at the 
bottom of the funnel. 
 
Table 1.2. Orwin's Fail Safe N Analysis to Evaluate Publication Bias 
Instrument
* 
N
† 
IKDC 95 
Lysholm 83 
KOOS 196 
MCKRS 48 
SF-36 PCS 14 
Overall Across All Instruments 399 
 *IKDC: International Knee Documentation Committee Subjective Knee Form, Lysholm: 
Lysholm Knee Scale, KOOS: Knee Injury and Osteoarthritis Outcome Score. MCKRS: 
modified Cincinnati Knee Rating System: SF-36 PCS: Medical Outcomes Study 36-Item 
Short Form Health Survey Physical Component Scale 
†Number of studies with an effect size of 0.1 needed to reduce the overall mean effect 
size to 0.4 
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Responsiveness of PROs 
Mean effect sizes and 95% confidence intervals (CIs) for each instrument at each 
of the four time points are reported in the Forrest plot in Figure1.3 and Figure 1.4.  For an 
instrument to be included in the meta-analysis at a given time point a minimum of 4 
individual data points must have been reported.  The WOMAC did not meet this 
requirement at any time point, and the SF-36 PCS only met this requirement at time point 
III.  The MCKRS could only be evaluated at time points III and IV and only the patient 
perception scale could be evaluated. 
Responsiveness within Instruments Across Time Points 
 For all evaluated instruments none of the mean effect sizes or confidence intervals 
encompassed zero, indicating that there is evidence of positive treatment effects following 
ACI regardless of the PRO utilized (Figures 1.3).  The IKDC was observed to have 
increasing responsiveness over time, as measured by Hedge’s g effect sizes, with time 
point IV demonstrating a significantly greater mean effect size (mean effect size [95 
CI%]: 1.78 [1.33, 2.24] than time point 1 (0.88, [0.69, 1.07]).  The responsiveness of the 
Lysholm varied little across time points with mean effect sizes only ranging from 1.29 to 
1.69. There was also no difference in responsiveness for the MCKRS between time points 
II and III.  Finally, the only KOOS subscale to show improvements in responsiveness 
over time was the KOOS-sports and recreation subscale for which time point III (1.76 
[0.87, 2.64] and time point IV (0.98 [0.81, 1.15] were significantly more responsive than 
time point I (0.61 [0.44, 0.78]). 
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Figure 1.3. Forrest Plot of Effect Sizes by Patient Reported Outcome Among 
Autologous Chondrocyte Implantation Patients
 
Random effects model summary mean effect sizes for each patient reported outcome 
instrument by time point. IKDC: International Knee Documentation Committee 
Subjective Knee Form, Lysholm: Lysholm Knee Scale, KOOS-ADL: Knee Injury and 
Osteoarthritis Outcome Score Activities of Daily Living subscale, KOOS-pain: Knee 
Injury and Osteoarthritis Outcome Score Pain subscale, KOOS-QOL: Knee Injury and 
Osteoarthritis Outcome Score Quality of Life subscale, KOOS-Sports: Knee Injury and 
Osteoarthritis Outcome Score Sports and Recreation subscale, KOOS-Symptoms: Knee 
Injury and Osteoarthritis Outcome Score Symptom subscale. MCKRS Patient: modified 
Cincinnati Knee Rating System Patient Perspective: SF-36 PCS: Medical Outcomes 
Study 36-Item Short Form Health Survey Physical Component Scale.  
-2 0 2 4
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KOOS-QOL
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Time II
14, 23, 69, 84, 121, 123, 171, 
186
 Time IV
50, 107, 115, 135, 137
 
Time III
66, 67, 121, 149, 185
 
Time IV
31, 50, 98, 108, 112, 
118, 185
 
Time III
66, 67, 84, 149
 
 
Time I
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Key:     Time I (0 to <1 year)     Time II (1 to < 2 years)     
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Figure 1.4. Forrest Plot of Effect Sizes by Time Point Among Autologous 
Chondrocyte Implantation Patients 
 
Figure 1.4. Random effects model summary mean effect sizes for each patient reported 
outcome instrument at each time point. IKDC: International Knee Documentation 
Committee Subjective Knee Form, Lysholm: Lysholm Knee Scale, KOOS-ADL: Knee 
Injury and Osteoarthritis Outcome Score Activities of Daily Living subscale, KOOS-pain: 
Knee Injury and Osteoarthritis Outcome Score Pain subscale, KOOS-QOL: Knee Injury 
and Osteoarthritis Outcome Score Quality of Life subscale, KOOS-Sports: Knee Injury 
and Osteoarthritis Outcome Score Sports and Recreation subscale, KOOS-Symptoms: 
Knee Injury and Osteoarthritis Outcome Score Symptom subscale. MCKRS Patient: 
modified Cincinnati Knee Rating System Patient Perspective: SF-36 PCS: Medical 
Outcomes Study 36-Item Short Form Health Survey Physical Component Scale. 
Responsiveness by Time Point 
At time point I the Lysholm (1.52 [0.92, 2.11]) was significantly more responsive 
than the KOOS-sports and recreation subscale (0.61 [0.44, 0.78]) (Figure 1.4). At time 
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point II both the IKDC (1.37 [0.93, 1.80]) and the Lysholm (1.53 [0.96, 2.11]) were 
significantly more responsive than the KOOS-sports and recreation subscale (0.57 [.23, 
.92]).  There were no significant differences between any of the instruments at time point 
III.  Finally, at time point IV the IKDC (1.78, [1.33, 2.24]) was significantly more 
responsive than the KOOS-sports and recreation subscale (0.98 [.81, 1.15]). 
Overall Responsiveness 
The final comparison was of the overall responsiveness of each instrument with 
data from all available time points combined (Figure 1.5).  This analysis demonstrated 
that overall the SF-36 PCS (0.60 [0.46, 0.74]) was significantly less responsive than all 
other instruments and subscales with the exception of the KOOS-sports and recreation 
subscale (0.87 [0.68, 1.07]).  Both the Lysholm (1.52 [1.25, 1.80]) and the IKDC (1.34 
[1.14, 1.54]) had overall mean effect sizes that were significantly greater than the overall 
mean effect size for the KOOS-sports and recreation subscale.  With all time points 
combined the Lysholm was also significantly more responsive than the KOOS-symptoms 
subscale (1.01 [0.83, 1.19]). 
 
Discussion 
The primary purpose of this study was to evaluate the responsiveness of common 
PROs to the treatment effects of ACI.  An underlying assumption of this review was that 
ACI would have a common effect across studies and varying ACI procedures.  While 
evaluating ACI efficacy was not a purpose of this review, the results of this systematic 
review and meta-analyses are in agreement with previous reviews documenting ACI to be 
a viable procedure resulting in positive patient outcomes.
62, 87, 176
  A strength of our 
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Figure 1.5. Forrest Plot of Summary Mean Effects Sizes Across all Time Points for 
Each Patient Reported Outcome 
 
Random effects model summary mean effect sizes for each patient reported outcome 
instrument across all time points combined. IKDC: International Knee Documentation 
Committee Subjective Knee Form, Lysholm: Lysholm Knee Scale, KOOS-ADL: Knee 
Injury and Osteoarthritis Outcome Score Activities of Daily Living subscale, KOOS-pain: 
Knee Injury and Osteoarthritis Outcome Score Pain subscale, KOOS-QOL: Knee Injury 
and Osteoarthritis Outcome Score Quality of Life subscale, KOOS-Sports: Knee Injury 
and Osteoarthritis Outcome Score Sports and Recreation subscale, KOOS-Symptoms: 
Knee Injury and Osteoarthritis Outcome Score Symptom subscale. MCKRS Patient: 
modified Cincinnati Knee Rating System Patient Perspective: SF-36 PCS: Medical 
Outcomes Study 36-Item Short Form Health Survey Physical Component Scale 
 
review is that we included a more comprehensive review of the available literature.  
Previous systematic reviews have limited study inclusion to evaluation of randomized 
controlled trials,
176
 comparisons to other cartilage treatments,
62
 or studies of the third 
generation MACI version of ACI.
87
  In previous reviews, the maximum number of 
included studies was 18
87
 while the present investigation included 42 studies.  Current 
inclusion criteria captured a wider variety of patients and defect locations representing all 
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surfaces of the tibiofemoral and patellofermoal joints.  The large mean effect sizes and 
narrow confidence intervals observed in this review support the use of ACI for the 
generalized treatment of articular cartilage defects.   
Responsiveness 
The results of this review demonstrate that regardless of the duration of post-
operative follow-up all instruments were responsive to patient improvement following 
ACI; however, the IKDC and Lysholm may be more responsive than the MCKRS, 
KOOS, or SF-36 PCS.  There was insufficient data to adequately evaluate the WOMAC. 
Responsiveness Within Patient Reported Outcome Instruments Across Time Points 
The Lysholm demonstrated large mean effect sizes (1.30 to 1.70) with little 
variation across the four examined time points (Figure 1.2).  The observed confidence 
intervals for the Lysholm at all four time points overlap by more than 50% suggesting 
little changes in responsiveness as time since ACI progresses.  Common rehabilitation 
recommendations following ACI restrict return to sports participation for 12 to 18 months 
following surgery. 
9, 53, 61
  This delayed return to physical activity may result in lower 
scores on instruments that emphasize higher demand sports activity.  Because the 
Lysholm primarily assess every day activities (walking, squatting, stair-climbing) and 
does not address sports activity, delayed return to higher level physical activity has little 
influence on Lysholm score.  The lower demand activities evaluated in the Lysholm are 
functional goals addressed early in rehabilitation, and patients may see little improvement 
in these activities beyond the 1 year time point.  The result is a potential ceiling effect for 
Lysholm scores which may explain its limited changes in responsiveness over time (i.e. 
confidence intervals overlap for all 4 time points).  Therefore, the Lysholm scale may be 
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ideal for evaluating short-term outcomes or outcomes among patients not intending to 
return to sports, but it is less responsive to changes seen during long-term recovery as 
individuals return to higher demand activities.  
The IKDC also demonstrated large effect sizes.  However, a significant increase in 
mean effect size was observed between time point I and time point IV with mean effect 
size increasing from 0.88 to 1.78 with no overlap between confidence intervals.  This 
difference demonstrates increased treatment effects over time when evaluating outcomes 
with the IKDC.  Greco et al. observed a similar trend with responsiveness of the IKDC 
increasing between 6 and 12 months in a cohort of surgical cartilage patients.
58
  It has 
previously been reported that functional and structural improvements following cartilage 
repair continue beyond 1 year postoperatively.
22, 90, 145
  The observed increases in mean 
effect size over time may represent the IKDC’s responsiveness to continual improvements 
in function that occur in the years following ACI surgery.  The responsiveness of the 
IKDC to continued improvements over time can be considered a strength of this 
instrument and may be due to its inclusion of sporting activities.  A wide variety of 
function can be documented with the IKDC, ranging from the inability to participate in 
any activity without symptoms to full participation in strenuous activities such as jumping 
or pivoting.  The IKDC allows for continued improvement as individuals initiate return to 
strenuous activity and sports participation beyond the one year postoperative time point.   
The KOOS-sports and recreation subscale had the lowest mean effect at time 
points I and II while the KOOS-symptoms subscale had the lowest mean effect of all the 
KOOS scales at time points III and IV.  Responsiveness as evaluated by the mean effect 
size for the KOOS-sports and recreation subscales was significantly lower at time point I 
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compared to time points III and IV.  These results are similar to that which was observed 
with the IKDC, and this progressive improvement in responsiveness over time may be 
related to the slow, progressive return to sports following ACI.  For all other KOOS 
subscales no significant changes were seen for mean effect size between time points with 
all confidence intervals overlapping.  Overall the KOOS was responsive to changes 
following ACI;  however, the KOOs-sports and recreation subscale was the only subscale 
to demonstrate increasing mean effect sizes over time, suggesting that it responded to 
increasing treatment effects as healing progressed.  
The MCKRS contains the fewest questions of the instruments included in this 
review, consisting of one to three questions.  Only the single item of the MCKRS had 
sufficient data for inclusion in the meta-analyses.  There was only sufficient data to 
evaluate the MCKRS at time point III and time point IV, limiting any conclusions that can 
be drawn regarding the changes in its responsiveness over time.  Although the results of 
this review suggest that the MCKRS is responsive to changes in patient function 
following ACI, caution is urged regarding the use of this instrument.  Many different 
versions of the MCKRS exist and many authors fail to reference the version of MCKRS 
they use.  Similarly, appropriate psychometric properties for the MCKRS have rarely 
been reported.  This made selection of appropriate studies difficult, for example,  several 
articles were excluded at least in part because the authors did not reference the version of 
the MCKRS utilized, or because a different version than the one presented by Browne et 
al.
31
 was utilized as an outcome measure.
7, 13, 20, 21, 57, 80, 90-92, 164
  Due to ambiguity 
regarding the use of “modified” Cincinnati Knee Rating Systems the developers of the 
original Cincinnati Knee Rating Scale discourage the use of any modified versions.
11
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However, because of the frequency with which the Browne et al.
31
 version of the MCKRS 
has been clearly referenced in the ACI outcomes study it was chosen for inclusion in this 
review. 
Both the SF-36 PCS and the WOMAC had limited data available for analysis. For 
the SF-36 PCS there was only sufficient data for analysis of responsiveness at time point 
III.  For this time point the SF-36 PCS did demonstrate a positive mean effect 2 to 4 years 
following ACI treatment with an effects size of 0.92[0.55,1.28].  There was insufficient 
data to include the WOMAC in any of the meta-analyses performed.  Only two studies 
were available that utilized the WOMAC and reported sufficient data for calculating 
effect sizes, and even these studies failed to report results for all three WOMAC 
subscales.
112, 149
   While additional studies have included the WOMAC as an outcome 
measure the results were only reported using non-parametric statistics and/or without the 
reporting of means and standard deviations, or other data necessary for calculating effect 
sizes.
110, 111, 113, 114
  As a result no clear conclusions regarding the responsiveness of the 
WOMAC as an outcome instrument can be reached based on this review. 
Responsiveness between Patient Reported Outcome Instruments 
The Forrest plots of PRO instruments by time point can be seen in Figure1.4, 
while the overall mean effect sizes across all time points can be seen in Figure 1.5.  The 
IKDC and the KOOS- sports and recreation subscales were the only instruments to 
demonstrate significant changes in responsiveness over time.  These changes may be 
related to activity restriction and gradual return to sports following ACI. The restrictions 
on sporting activity during the first year post-ACI may also explain the significant 
differences observed between the responsiveness of the KOOS-sports and recreation 
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subscale and the Lysholm at time points I and II (Figure 1.4).  At time point II and time 
point IV the IKDC was more responsive than the KOOS-sports and recreation subscale.  
These differences may be the result of the wider range of physical functioning addressed 
in the IKDC as compared to the KOOS-sports and recreation subscale.  At both time point 
III and time point IV the confidence interval surrounding the mean effect size for the 
MCKRS overlapped with the confidence interval for all other instruments, indicating that 
the responsiveness of the MCKRS was not significantly different from any other 
instrument evaluated.  Overall and at time point III the SF-36 PCS had the lowest 
responsiveness as measured by mean effect size.  This finding is not surprising given that 
the SF-36 is the only included instrument not designed specifically for the evaluation of 
knee function.  The SF-36 may be more useful when evaluating HRQOL; while the 
IKDC, Lysholm, MCKRS, and all KOOS subscales, with the exception of the sports and 
recreation subscale, are more responsive than the SF-36 PCS to changes in knee function 
following ACI. 
Examination of  overall responsiveness without regard to individual time points 
demonstrates that the Lysholm and IKDC were observed to have the largest mean effect 
sizes with significantly greater responsiveness than the KOOS-sports and recreation 
subscale and the SF-36 PCS (Figure 1.5).  While both the KOOS and IKDC include 
sports participation as components of evaluating knee function, the IKDC is significantly 
more responsive to overall changes in function following ACI (Figure 1.5).  This overall 
difference, combined with the significant differences in responsiveness between the 
IKDC and KOOS-sports and recreation subscales at time points II and IV leads us to 
propose that the IKDC may be the preferred outcome instrument for evaluating long-term 
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outcomes following ACI, particularly among patients whose goals include return to 
sporting activity.  Although all KOOS subscales are responsive to treatment effects 
following ACI, the IKDC and Lysholm are shorter instruments with single score 
outcomes and overall are more responsive to change than some subscales included in the 
KOOS.  Based on these observations, the IKDC and the Lysholm may be preferable to the 
KOOS for documenting treatment effects following ACI. 
Study Quality 
The mean modified Coleman Methodology score (50.9 + 9.2) among studies 
included in this review was comparable to other recent reviews of ACI and other cartilage 
repair procedures.  Harris et al. reported a mean modified Coleman Methodology score of 
54 in 13 studies comparing ACI to other cartilage repair treatments.
62
  Evaluation of 
MACI procedures resulted in observed scores of 53.1 + 1.5.
86
  In a general review of 
cartilage repair procedures using a different variation of the Coleman Methodology Score, 
Jakobsen et al. reported a mean score of 43.51 + 12.1.
81
  The slightly lower methodology 
score observed in our review compared to those by Harris et al.
62
 and Kon et al.
87
 is not 
surprising given the broad inclusion criteria for this review which did not seek to compare 
different cartilage repair techniques or different generations of ACI.  Also, the present 
review included several studies that are over 5 years old and a general trend towards 
increasing study quality over time has been previously reported.
62
  Regardless of the 
selection criteria utilized, this review and others demonstrate the need for improved 
research methodology and reporting of outcomes in future cartilage repair investigations 
While the modified Coleman Methodology Score reported in this review provides 
a set of standardized criteria by which to evaluate cartilage research, it is not without 
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limitations.  The scale is heavily weighted towards diagnostic, clinician based outcomes 
with up to 20 points of the 100 point score dependent on MRI and histological evaluation.  
The relationship between MRI and clinical outcome is not definitive with some authors 
observing low to moderate correlations between MRIs and PROs, 
34, 101, 146
 and others 
failing to observe such a relationship.
167, 175
  Similarly, histological analysis can involve a 
wide variety of techniques and may not be ethical in cases where reoperation is not 
otherwise indicated.  Of the 42 studies included in our review only a single study
158
 
received full credit for both histological and MRI outcomes, suggesting that the 
requirement of these outcomes may not be applicable in a clinical research setting.  
Other areas where the included studies received less than 50% of the possible 
methodology points available on average were the reporting of recruitment rate 
(documented in only 2 studies
149, 185
), investigator independence, duration of follow-up, 
and number of different surgical procedures included.  Only 8 studies clearly stated that 
the investigator documenting outcomes did so independently from the operating 
surgeon.
27, 31, 84, 98, 112, 149, 152, 158
  To receive the full 10 points allotted for duration of study 
follow-up, outcomes beyond 60 months were required to be reported, a requirement that 
was only met by 5 studies.
31, 54, 86, 118, 137
  Finally, only 5 studies scored a full 10 points for 
> 90% of subjects undergoing one surgical procedure with less than 10% undergoing 
concomitant procedures.
16, 69, 84, 150, 158
  It is important to note that while common 
concomitant procedures such as osteotomies, meniscal allograft transplants, or ligament 
reconstructions reduced the overall methodological score, studies that included these 
procedures are much more generalizable to real clinical practice than studies of single 
isolated defects.
46
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Limitations 
The results of this review are limited by the quality and strength of the studies and 
PROs selected for inclusion.  As evidenced by the low modified Coleman Methodology 
Score observed in this review and others, the quality of reporting in cartilage outcomes 
studies is variable and generally poor.  Similarly, the included studies presented an 
expansive range of patients of various ages, with chondral defects of varying size and 
location, and who underwent an assortment of concomitant procedures.  A random effects 
analysis was utilized to account for the variability between studies allowing our results to 
be generalized to a broad clinical population.   
Numerous other PROs could have been selected for inclusion in this review; 
however, only the IKDC, Lysholm, MCKRS, KOOS, SF-36 PCS, and WOMAC were 
selected for review.  As a result the conclusions drawn from this study can only be 
applied relative to these PROs.  These PROs were chosen based on the interest of the 
authors, their established psychometric properties, and the frequency of their use within 
the articular cartilage literature.   
Finally, a statistical limitation of our study is the use of multiple measures at 
multiple time points from within the same study populations.  For studies with multiple 
outcome measures (Example: both IKDC and MCKRS) all evaluated outcome scores 
(Example: 1 year and 3 years) were included as independent measures.  We acknowledge 
that outcome scores obtained from within the same sample are likely correlated, but given 
that the correlation between outcome measures and time points is rarely reported, 
correction for this relationship was not feasible.  Fortunately, the observed mean effect 
sizes are so large and the confidence intervals so small for the included outcome 
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instruments that we do not believe this assumption violation significantly influences the 
overall conclusions of this review. 
 
Conclusions 
Evidence for the use of ACI as a treatment for chondral defects consists primarily 
of level 2b observational cohort studies.  The methodological quality of many of these 
studies is limited by the absence of diagnostic outcomes such as MRI and histological 
analyses, small sample size, short-follow-up, and high frequency of concomitant 
procedures. In addition documentation of recruitment rate and investigator independence 
was lacking from many studies.  The IKDC, Lysholm, KOOS, MCKRS, and SF-36 PCS 
were all responsive to improvements in function following ACI.  A positive treatment 
effect for ACI was observed using all instruments with follow-up time points ranging 
from less than one year to beyond 4 years.  The Lysholm and the IKDC were the most 
responsive instruments across time points.  The Lysholm was highly responsive as early 
as less-than 1 year following ACI and was consistently responsive throughout 
postoperative follow-up.  However, this instrument may not be responsive to changes in 
function associated with the resumption of higher demand activities such as sports which 
occurs after the one year time point.  For the evaluation of long-term outcomes among 
patients with an intent to return to physical activity, this review supports the use of the 
IKDC which was able to detect increasing treatment effects overtime.  The use of the 
Lysholm and IKDC together represents a responsive combination of PRO instruments 
that are able to efficiently document both short term and long-term treatment effects 
among patients of a variety of activity levels following ACI.  
 
38 
 
CHAPTER 2: RELIABILITY OF FORCE PLATE BASED PERFORMANCE 
MEASURES FOR EVALUATION OF PATIENTS RECEIVING TREATMENT FOR 
KNEE ARTICULAR CARTILAGE DEFECTS 
 
INTRODUCTION 
With any form of medical treatment the ability to accurately and objectively 
document outcomes is of the utmost importance. This is particularly true in areas with 
new and emerging therapies such as the treatment of articular cartilage defects. Within 
this rapidly evolving field a variety of different outcomes can be used to evaluate 
treatment success. The types of outcomes collected can be classified as disease oriented, 
patient oriented, or performance based outcomes. Disease oriented outcomes are those 
that are of primary interest to the clinician. Disease oriented outcomes include elements 
such as Magnetic Resonance Imaging, graft biopsy, range of motion, or swelling. Patient 
oriented outcomes emphasize health related quality of life and focus on the ability to 
return to work, social, and recreational activities, and are commonly collected using 
patient reported outcome instruments (PROs) such as pen and paper questionnaires. 
Finally, performance based outcomes/assessments (PBAs) focus primarily on activities or 
functional tasks such as squatting, walking, hopping, or performing a standardized series 
of movements that can be objectively quantified by a measurement of kinematic or kinetic 
variables (e.g. distance, time, pressure, force, repetitions). All three types of outcomes are 
relevant in determining the successfulness of treatment and should be included in any 
comprehensive outcomes study. Regardless of the type of outcome being considered it is 
imperative that the method being used to measure it is reliable.  
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In the existing literature the predominant outcome measure for articular cartilage 
treatment via autologous chondrocyte implantation (ACI) has been patient oriented 
outcomes documented using PROs.
21, 29, 31, 44, 49, 51, 86, 90, 98, 108, 115, 116, 149, 185
  Common PRO 
instruments including the Lysholm scale 
85
, International Knee Documentation 
Committee Subjective Knee Form
58
, modified Cincinnati Knee Rating System
58
, Knee 
Osteoarthritis Outcomes Score
17
, and Western Ontario and McMaster Universities 
Osteoarthritis Index
58, 147
 have been evaluated for reliability among cartilage patients. 
One common form of disease oriented outcome evaluation is grading of the 
articular cartilage from direct visualization during a second look or follow-up 
arthroscopy. The reliability of multiple visual inspection scales have been evaluated 
among articular cartilage and specifically ACI patients.
161, 174
 In general, observational 
evaluation of articular cartilage via arthroscopy has acceptable intrarater reliability (ICC = 
0.65
174
 to 0.94
161
), but interrater reliability and agreement may be highly variable and 
specific to each individual group of raters(ICC = 0.52
32
 to 0.83
161
). 
32, 102, 161, 174
 These 
disease oriented outcomes are one of the few outcomes that have been specifically applied 
to an ACI patient population. However, they are also the least practical outcome measure 
to universally collect on ACI patients. In medical practice a second look arthroscopy 
cannot ethically be performed routinely. These follow-up surgeries will only be 
performed in patients who report dissatisfaction with treatment outcomes or new injury, 
resulting in a biased sample. Research is ongoing into less invasive assessment techniques 
such as magnetic resonance imaging to reliably document cartilage healing and 
structure.
83, 95, 140
  While these techniques may provide a quality evaluation of tissue 
structure and healing, they are not cost effective across large populations, and physical 
structure may not always relate to pain and function levels.  
 
40 
 
Performance based testing, particularly of the lower extremity, has been suggested 
as part of a comprehensive rehabilitation program for several years.
12, 63
 However, there 
are few clear cut recommendations as to what form lower extremity PBAs should take. 
The ultimate goal of performance based testing is to asses function by recreating forces 
similar to those the body experiences during normal activity or participation.
94
 This form 
of outcomes assessment is relatively new within the ACI literature and is only known to 
have been reported in three outcome studies thus far.
44, 146, 172
 In these studies the 6 minute 
walk test
44, 47, 146
 and a series of single limb hopping tasks
172
 were the assessments 
evaluated. The reliability for these tests or any other PBA has not been established among 
patients undergoing articular cartilage repair of the knee.  
PBA measures should at minimum have the potential to be evaluated pre-
operatively and at long-term (e.g. ≥1 year) follow-up. Ideally a measure will also be 
suitable for repeated testing throughout the recovery process. The NeuroCom Balance 
Master
®
 and long force plate(LFP) (NeuroCom International, Clackamas, OR) together 
are a commercially available system designed both as a training and evaluation tool for 
functional and balance tasks.
5
 This system has the ability to provide immediate feedback 
to clinicians and patients regarding quality of task performance for a variety of activities 
of daily living (ADLs). Additionally, performance values are saved in individual patient 
files for easy comparison to evaluate progress over time. Tasks that are part of the LFP 
testing protocol that simulate ADLs and have potential as ACI outcome measures include 
the unilateral stance, weight bearing squat, sit-to-stand, rhythmic weight shift, step-up and 
over, and the forward lunge.  These outcome measures are of low to moderate demand 
and should be feasible for performance by ACI patients throughout much of the recovery 
process.  However, for these tasks to be useful as assessments, they must be reliable 
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across time points to document changes in function following surgical treatment.  
Therefore, the purpose of this study was to evaluate the reliability of a series of force 
plate based PBAs among ACI patients. 
 
METHODS 
Participants 
Twenty-one patients (12 males, 9 females, age 36.4 ± 6.8 years, weight 93.8 ± 
21.1 kg, height 175.9 ± 12.1 cm) being treated for articular cartilage defects to the knee 
participated in this study. Prior to study enrollment all patients provided institutional 
review board approved informed consent. This was a repeated measures study design with 
subjects tested 2 times within the same data collection period to evaluate test-retest 
reliability. To assess the reliability of measures at various stages of treatment, patients 
were either enrolled at their preoperative appointment prior to undergoing ACI (n=9) or at 
their 1 year follow-up appointment following ACI (n=12). Nine participants (4 
preoperative) were undergoing treatment for defects to the tibiofemoral joint, while 12 
participants (5 preoperative) underwent treatment to the patellofemoral joint that included 
tibial tubercle transfer in addition to ACI. 
Performance Based Assessments (PBAs):  
Each participant completed a series of seven functional tasks performed on the 
LFP.
5
 The LFP consists of a 45.72 cm x 152.40 cm force plate with data sampled at 100 
Hz and a personal computer equipped with data capture software (Balance Master ver. 
8.1). These functional tasks were selected because of their direct relationship to activities 
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of daily living and the feasibility of patients being able to complete the task at each testing 
time point (Table 2.1). Tests were completed for both testing sessions in the order 
presented in Table 2.1, which was determined to be from least to most demanding based 
on patient reporting of difficulty during pilot testing. All testing was administered by the 
same investigator (JSH). For all single limb tests the uninvolved limb was tested first. 
Three successful trials of each task were performed, except for the Weight Bearing Squat 
which consisted of a single trial at each joint angle and the Rhythmic Weight Shift which 
consisted of one trial at each speed in each direction.  Approximately 15s of rest was 
provided between each trial and 30s of rest between each task.  Following a minimum of 
a 15 minute rest period all tests were repeated on the same day. Before, and after each 
testing session participants were asked to verbally rate their knee pain on a 0-10 scale. 
Changes of more than 2 points between the start of testing sessions were considered to 
represent a meaningful change in pain and these participants were excluded from the 
reliability analysis. All outcome variables are identified using the names assigned to them 
by the software used, and are defined in Table 2.1. The seven tasks are described below.   
Walk Across: Patients walked across the LFP using their freely chosen standard gait speed 
and pattern.  
Weight Bearing Squat: Patients stood still on the force plate at the initial measure was 
recorded with knee flexion angles of 0˚, 30˚, 60˚, and 90˚as tolerated 0˚). They then 
flexed their knees and held positions at 30˚, 60˚, and 90˚as tolerated. The percentage of 
body weight on the involved limb was measured during a single trial with a duration .01s 
for each position.  A standard goniometer was used to verify joint angle at each position. 
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Table 2.1 Functional tasks evaluated on the NeuroCom Balance Master ® Long 
Force Plate.  All tasks were performed in the order presented by patients treated for 
articular cartilage defects to the knee. 
Task Parameter 
Assessed 
NeuroCom Outcome 
Variable 
Definition 
Walk 
Across 
Characterization of 
Gait 
Stride Length (cm) Distance between contralateral heel strikes  
  Stride Width (cm) Lateral distance between center of pressure of left 
and right foot strikes 
  Walking Speed (cm/s) Speed of forward progression of the center of 
gravity (COG) 
Weight 
Bearing 
Squat 
Proprioception, 
Strength 
% Body Weight (BW) at 0° 
(full extension), 30°, 60°, 
and 90° of knee flexion 
% BW on the involved limb at each position (test 
duration .01s) 
Unilateral 
Stance 
Balance Center of Gravity (COG) 
Sway Velocity (deg/s) 
Angular displacement (angle between the center of 
pressure to theoretical COG vector and horizontal 
vector) divided by the 10s duration of the trial 
Sit To 
Stand 
Strength and 
Double Limb 
Balance 
Weight Transfer time (s) Time required from start of motion while sitting (i.e. 
increase in center of pressure(COP) forward 
velocity by 5% from resting velocity) to achieve full 
weight bearing standing (i.e. forward velocity drops 
to within 5% of standing resting velocity) 
  Rising Index (%BW) Peak vertical force exerted through the legs when 
rising to full standing relative to stationary vertical 
standing force 
  COG Sway Velocity 
(deg/s) 
Angular displacement (angle between the center of 
pressure to theoretical COG vector and horizontal 
vector) divided by the time to rise and the first 5s 
following rising 
  Weight Symmetry % Difference in weight supported by each limb 
during the weight transfer phase 
Rhythmic 
Weight 
Shift 
Postural Control On-Axis Velocity (deg/s) Average speed of movement in the target direction 
  Directional Control (ratio) Ratio of movement in the intended direction to 
extraneous movement away from the intended 
direction 
Step-
up/Over 
Concentric 
Strength and 
Eccentric Control 
Lift-up Index (%BW) Peak vertical force occurring while stepping up 
onto the box as a percentage of body weight 
  Impact Index (%BW) Peak vertical force occurring while stepping down 
off the box as a percentage of body weight 
  Movement Time (s) Time between initial weight shift (i.e. change in 
COP velocity by 5%) and contact with force plate 
on opposite side of box (determined by COP 
velocity dropping to within 5% of post-test resting 
velocity) 
Lunge Concentric and 
Eccentric Control, 
Functional Range 
of Motion 
Distance (% subject 
height) 
Length of lunge step as a percentage of subject 
height 
  Movement Time (s) Duration of lunge phase during which lead leg is in 
contact with the force plate. Start and stop of a trial 
is determined by 5% change in COP velocity from 
pre-test and post-test resting velocity. 
  Impact Index (%BW) Peak vertical force occurring during lunge 
maneuver as a percentage of body weight 
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Unilateral Stance: Patients stood on each leg and maintained their balance for 10 s with 
their eyes open. They begin with the non-weight bearing leg flexed at about 60-80˚ and 
with their hands on their hips. If patients touched down, or their legs touched each other, 
testing was stopped and the trial was discarded. Testing of a condition was discontinued if 
a participant experienced three consecutive failed trials. Testing was repeated for both 
legs with the patients’ eyes closed.   
Sit to Stand: Patients were seated on a 50cm box.  Upon both visual and audio signal from 
the computer they rose to full standing as quickly as possible without using their hands, 
and then maintained a steady stance for the remainder of the 10 s trial.  
Rhythmic Weight Shift: Patients stood on the force plate and shifted their center of gravity 
(COG) rhythmically left to right or front to back between targets at 1s, 2s, and 3s 
intervals.  Both visual and audio cues were provided for pacing, as was visual feedback 
for the position of the COG.  One trial consisted of three complete cycles between targets.  
One trial was completed at each speed/direction combination. 
Step-Up/Over: Participants stood behind a 29cm high box and stepped up onto the box 
with their test leg, then brought their non-test leg up and over the box, and then stepped 
down with their test leg. This was performed as quickly as possible while still maintaining 
control.  
Forward Lunge: Patients in a standing position stepped forward on one leg and squatted 
down as far as comfortably possible, and then returned to the initial standing position as 
quickly as possible.  
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Statistical Analysis 
Outcome variables were averaged for the three trials on the involved limb for each 
task, except for the Weight Bearing Squat and the Rhythmic Weight Shift.  For the 
Weight Bearing Squat a single trial at each joint angle was examined.  For the Rhythmic 
Weight Shift on axis velocity and directional control were averaged across speeds for 
each direction (right-to-left and front-to-back) to provide a composite score for each 
variable in each direction. The descriptive statistics of minimum, maximum, mean and 
standard deviation (SD) were used to summarize the data. Intraclass correlations 
(ICC(2,1)) were used to evaluate the test re-test reliability of each outcome measure. For 
unilateral tests, only the reliability of the involved (surgical) limb was analyzed. All tests 
with ICC greater than or equal to 0.75 were considered to have acceptable reliability as a 
PBA for documenting outcomes following ACI. Standard error of measurement 
(SEM=SD(√(1-ICC)) values were also calculated to provide a clinical context to the data 
by reporting the response stability in the actual units of measures.
138
 The SEM represents 
the range of scores that can be expected on re-testing. PASW 18.0 (SPSS Inc., Chicago, 
IL) was used for all statistical analyses.  
 
RESULTS 
All Patients 
The resulting descriptive and reliability statistics are reported in Table 2.2.  No 
patients were excluded from the analysis due to changes in self-reported pain between 
testing sessions. ICC values when all patients were analyzed as one group ranged from 
0.38 to 0.94. For the Walk Across, both stride length and speed demonstrated acceptable  
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reliability (ICC≥0.75). For the Weight Bearing Squat only squatting at 90° of knee flexion 
demonstrated acceptable reliability. Both eyes open and eyes closed Unilateral Stance on 
the involved limb showed acceptable reliability. For the Sit-to-Stand only the rise force 
met the reliability standard. Both left-right and front-back composite on axis velocity for 
the Rhythmic Weight Shift were reliable. The Step Up/Over was reliable for lift-up index, 
movement time, and impact index. Finally, distance, impact index, movement time, and 
impulse were reliable for the Forward Lunge.  
 
Preoperative vs. Postoperative 
Among preoperative patients ICC values ranged from .32 to 0.99. Among patients 
12 months post ACI, ICC values ranged from .14 to .98. The Weight Bearing Squat at 90° 
was observed to be reliable in the preoperative group (ICC=0.87), but not in the 
postoperative group (ICC=0.34). Walk Across speed (pre ICC=0.62, post ICC=0.82) and 
Rhythmic Weight Shift left-right directional control composite score (pre ICC=0.45, post 
ICC=0.80) were the only variables observed to have acceptable reliability in the 
postoperative group but not in the preoperative group. For the remaining variables 
observed to have acceptable reliability across groups ICC values differed by less than 
0.10 between preoperative and postoperative patients. 
 
DISCUSSION 
The purpose of this study was to investigate the reliability of a series of tests using the 
NeuroCom Balance Master
®
 long force plate among knee cartilage patients. These tests 
represent potential performance based outcomes to serially evaluate treatment progress 
and success following ACI or other cartilage repair and restoration procedures. For each 
 
49 
 
of the tests evaluated, at least one outcome variable was observed to have acceptable 
reliability with ICC≥0.75. Overall the most reliable task was the Step Up/Over and the 
least reliable task was the Weight Bearing Squat.  
To our knowledge this is the first study to evaluate the reliability of LFP measures 
in a pathologic knee population. NeuroCom International has previously reported 
reliability among healthy participants for all of the tests evaluated with the exception of 
the Rhythmic Weight Shift.
3
 This reliability consisted of Pearson product moment 
correlation coefficients (r) calculated “by performing linear regression analysis.”
3
 One 
limitation to the use of these simple linear analysis tests is that systematic differences 
cannot be detected between testing sessions, which may occur due to a learning effect. 
Other authors using the NeuroCom system have frequently referenced these correlation 
values as being acceptable. 
6, 180, 183
 Despite the limitations of the NeuroCom International 
data, the correlation coefficients they report are similar to those we observed with r values 
ranging from 0.35 to 0.93.
3
  
Elsewhere in the literature, “Good to excellent” 
173
  reliability for the unilateral 
stance and forward lunge among healthy participants was referenced by Willems et al.
184
 
Additionally, independent intertester and intratester reliability has been established in 
active females for the Step-Up/Over and the Forward Lunge with ICC values ranging 
from 0.59 to 0.93.
119
 It should be noted that the ability to interpret and generalize these 
authors’ findings is limited due to the use of ICC equation (3,k). By definition reliability 
calculated using model 3 is only applicable for the examiner for whom the reliability has 
been calculated and cannot be generalized to other potential examiners.
160
 Finally, the use 
of only healthy, female participants in this study limits its generalizability to more diverse 
clinical populations including knee patients. 
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Despite the differences between studies, a comparison between our results and 
Naylor and Romani
119
 demonstrates similar reliability values, even in the presence of 
different performance means. Both studies reported acceptable intratester reliability for 
these measures.  Compared to Naylor and Romani we observed slightly higher ICCs for 
lift-up index (0.93 our study vs. 0.68 to 0.79) and impact index (0.89 our study vs. 0.83) 
and identical values for movement time (0.92).
119
 Similar results were seen for the 
Forward Lunge where ICCs ranging from 0.72 to 0.93 were observed, while Naylor and 
Romani reported values from 0.71 to 0.93. Furthermore, differences between patients 
with a known pathology and healthy participants represent a level of face validity for 
these NeuroCom tests. For example, when comparing our results to those reported by 
Naylor and Romani lower functional scores were observed among our pathologic patients 
than their healthy female controls.
119
 During the Step Up/Over our patients demonstrated 
lower lift-up index (46% vs 48% to 54%) and impact index values (49% vs. 55% to 65%), 
but longer movement times (1.47s) compared to the healthy athletic female participants 
(1.03 to 1.09s).
119
 During the Forward Lunge ACI patients demonstrated shorter lunge 
distance (48% vs. 53% to 57%) and lower impact index (24% vs. 39 to 42%), but longer 
movement time (1.29s vs. 0.73s to 0.77s) in comparison to those values reported among 
healthy, athletic females.
119
 Despite these performance differences, similar reliability was 
observed in our study compared to that previously reported for all forward lunge variables 
with both studies demonstrating reliability above the 0.75 threshold for lunge distance, 
impact index, movement time and impulse. 
The outcome measures where reliability fell below the a priori threshold of 0.75 
were Walk Across width; Weight Bearing Squat at 0°, 30°, and 60°; Sit to Stand weight 
transfer time and center of gravity sway velocity; and the Rhythmic Weight Shift 
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directional control moving left-right or front-back. For the Weight Bearing Squat the 
variability of this task may be higher than the other tasks evaluated due to the nature of 
the data collected. Unlike other measures where the average of three trials is recorded as 
the outcome variable, per the NeuroCom protocol, only a single trial at each position is 
recorded for the Weight Bearing Squat. Furthermore, the testing protocol for the Weight 
Bearing Squat captures the percentage of weight bearing for only a single data point at the 
time the test is initiated. The averaging of multiple trials at each position may improve the 
reliability of this test. A similar effect may exist with the Rhythmic Weight Shift where 
the computer software is designed to collect only one trial at each speed. Lower reliability 
values were also observed for width of the Walk Across task (ICC=0.68). This task 
demonstrated a learning effect as our participants had a 2.6 cm narrower stride during the 
second testing session. Narrowing of the stride is considered to represent improved 
function as an individual becomes comfortable with a narrower base of support.
3
 
Therefore, this improvement may be a result of individuals becoming more comfortable 
with the testing apparatus and laboratory environment over time, thus reducing our 
reliability values. Since the Walk Across was the first overall test, the reliability of this 
test may be improved by providing participants with more time to acclimate to the testing 
procedures.  
One goal of this study was to examine the reliability of LFP tasks across levels of 
function within the same patient population. This was investigated by including both 
preoperative and 12 month postoperative patients in the study population. Although there 
were some differences in reliability between preoperative and postoperative groups, in 
general outcome measures that were observed to be reliable in one group were reliable in 
the other. The exceptions to this were the Walk Across speed, Weight Bearing Squat at 
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90°, and Rhythmic Weight Shift right-left directional control composite score. Each of 
these had ICC values ranging from 0.62 to 0.76 when examined across groups and 
potential threats to reliability that have already been discussed. Specifically, the Walk 
Across and Rhythmic Weight Shift reliability may have increased over time due to a 
potential learning effect among 12 month patients who had more experience with these 
tasks due to previous exposure as part of an ongoing outcomes study. Overall for each 
task, with the exception of the Weight Bearing Squat, at least one outcome variable was 
observed to have acceptable reliability among both preoperative and postoperative 
patients.  
Limitations 
Patients were evaluated preoperatively and one year postoperatively, hence 
reliability at interim time points cannot be assessed. Reliability was assessed intraday as it 
was anticipated that the greatest threat to reliability would be a learning effect for the tests 
utilized, hence any interday affects have not been investigated. In this study we examined 
reliability of the long force plate measures, and did not evaluate the responsiveness of 
these measures to treatment progress.  
 
CONCLUSION 
PBAs have the potential to provide further insight into patient outcomes following 
ACI. However, PBAs must be reliable to be effective for evaluating patient progress over 
time. The NeuroCom Balance Master
®
 Long Force Plate is capable of reliably evaluating 
ACI patient performance of movements utilized during ADLs. Lower extremity function 
was most reliably assessed by the step up/over and lunge tasks for which ICC values 
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ranged from 0.78 to 0.93, demonstrating consistent evaluation in a pathologic knee 
population. Additionally, select outcome variables associated with the Walk Across, 
Weight Bearing Squat, Unilateral Stance, Sit to Stand, and Rhythmic Weight Shift were 
also observed to have acceptable reliability (ICC≥0.75). Furthermore, this instrument 
demonstrated reliability across a variety of levels of function among both preoperative 
patients and those one year post ACI surgery. 
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CHAPTER 3: PATIENT ORIENTED AND PERFORMANCE BASED OUTCOMES 
FOLLOWING KNEE AUTOLOGOUS CHONDROCYTE IMPLANTATION 
 
INTRODUCTION 
 Autologous chondrocyte implantation (ACI)
28
 has become an acceptable and 
common treatment approach for the management of symptomatic articular cartilage 
defects.
61
  As research regarding ACI has advanced sizable efforts have been made to 
evaluate both disease and patient oriented outcomes following ACI.  Numerous studies 
have evaluated the utilization of patient reported outcomes (PROs) to document the 
recovery of function and return to activity following ACI.
74
  Meta-analyses of more than 
43 studies have revealed large effect sizes demonstrating significant improvement for a 
variety of PRO scores following ACI.
74
  PROs provide reliable and valid information 
regarding patients’ perceived function and health related quality of life (HRQL).  An 
alternative to PROs is the use of performance based assessments (PBAs) to document 
outcomes.  PBAs provide a direct, objective measure of patient function and involve 
measures of performance such as time, distance, or force for specified tasks or 
movements.  The relationship between PROs and PBAs has previously been reported as 
low to moderate among a variety of knee patients.
52, 79, 82, 117, 120, 159
  Recent research 
involving total joint arthroplasty patients has provided further support for the inclusion of 
PBAs as part of a detailed outcomes assessment protocol.
79, 117, 166
   The combining of 
PROs with PBAs may provide a more complete picture of clinical outcomes after ACI 
than the utilization of either type of outcome in isolation. 
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Few studies have utilized PBAs to document the return of function following ACI.   
Those that have, have either examined very low demand activity such as the 6 minute 
walk test,
44, 45, 146
 or very high demand activity via the single-limb hop.
172
  No known 
studies have examined the timeline for return to function following ACI using low to 
moderate demand PBAs that recreate the demands and stresses of common activities of 
daily living such as squatting, rising from sitting, or going up and down stairs, in addition 
to walking.  Nor has the relationship between PROs and PBAs been examined in an ACI 
patient population.  An accurate description of functional recovery during the first year 
following ACI is imperative to provide evidence for prescription of appropriate patient 
education, rehabilitation protocols, and understanding of the recovery process.  
Furthermore, an understanding of the relationship between PROs and PBAs will provide 
key information regarding the importance of collecting varying types of outcomes in 
future cartilage repair research.  At present PROs are the accepted standard for functional 
outcomes in cartilage research; however, if PRO scores are not correlated with PBAs then 
both outcome measures may be necessary to document both perceived and physical 
changes in patient function following ACI.  Therefore, the purpose of this study was to 
document serial changes in knee function over one year following ACI using both PROs 
and PBAs and to explore the relationship between PROs and PBAs during recovery 
following ACI.  It was hypothesized that PROs would demonstrate significant 
improvement from baseline at all postoperative time points.  It was also hypothesized that 
PBA measures for walking, rising from sitting, stepping up/over, and lunging would 
demonstrate no improvements at the 3 month time point followed by progressive 
improvement at 6 months and 12 months as compared to baseline measures of function.  
Finally, it was hypothesized that  a significant relationship (P ≤ 0.05) would exist between 
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all PRO scores and performance measures for walking, rising from sitting, stepping 
up/over, and lunging at all time points with both forms of assessment demonstrating 
positive improvements over time. 
 
METHODS 
Patients 
 Beginning in July 2009 patients were prospectively recruited from an active 
cartilage center.  Inclusion criteria were planned ACI surgery to the medial or lateral 
femoral condyle, trochlea, or patella; willingness to participate and no uncorrectable 
contraindications to ACI such as extensive degenerative joint disease, insufficient 
meniscus, or unstable knee; and ability to ambulate without use of assistive devices.  
There were no exclusions based on limb malalignment if the malalignment was corrected 
prior to or at the time of surgery via high tibial osteotomy or tibial tubercle transfer.  
Similarly, patients undergoing concomitant or staged ligament reconstruction to correct 
joint instability were also eligible for study participation.  Patients undergoing 
concomitant meniscal transplant were excluded. 
A total of 29 patients (17 males, 12 females, 36.3 ± 6.9 yrs, 174.4 ± 9.6 cm, 90.4 ± 
19.4 kg)  agreed to participate.  Three patients were invited to take part of the study, but 
declined to participate resulting in an enrollment rate of 90%.  Of the enrolled patients 13 
underwent ACI to the patellofemoral joint with a tibial tubercle transfer and the remaining 
16 underwent ACI to the medial femoral condyle, of which 4 also had a concomitant high 
tibial osteotomy.  Mean number of defects treated per patient were 1.38 ± 0.6 with an 
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average treatment area of 6.6 ± 2.5 cm2 (range 2.3 to 13.0 cm2).  All participants signed a 
university approved IRB consent form at the time of enrollment. 
Surgical Procedures and Rehabilitation 
 All patients underwent a two-step ACI procedure performed by the same surgeon 
(CL).  During the first procedure a limited chondroplasty was performed and the lesion 
was evaluated arthroscopically.  At this time a biopsy was obtained from the intracondylar 
notch (100 to 200 mg cartilage).  This sample was sent to a commercial laboratory where 
it was cultured and expanded (Carticel, Genzyme Corp, Cambridge, MA).  In a second 
surgical procedure chondrocyte implantation was performed using a mini-
arthrotomy.  First the defect or defects were prepared using a curette to debride down to 
the subchondral plate with stable edges.  A type I/III collagen membrane (Chondro-
Gide 
(R)
 , Geistlich Biomaterials, Wohousen, Switzerland) was shaped to match the 
defect.  Sutures and fibrin glue (Tisseel, Baxter Healthcare Corp., Deerfield, IL) were 
used to adhere the membrane over the defect to form a water tight seal.  The chondrocytes 
in suspension were then injected beneath the membrane into the defect through a small 
portal remaining at the edge of the collagen membrane.  The portal was then closed and 
sealed with sutures and additional fibrin glue. 
 All patients followed standardized rehabilitation protocols following surgery.
93
  
All patients were braced in full extension and were non-weight bearing for 2 weeks 
postoperatively.  Toe-touch weight bearing was permitted from 2 to 4 weeks with partial 
weight bearing from 4 to 6 weeks and progression to full weight bearing between weeks 6 
to 12.  Continuous passive motion was prescribed for all patients for 6 to 8 hours per day 
for 6 weeks.  For defects in the tibiofemoral joint knee braces were gradually unlocked 
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between 2 to 4 weeks as quadriceps control was gained.  For defects to the patellofemoral 
joint knees were braced in full extension for weight bearing through 4 weeks 
postoperative and then were gradually unlocked as quadriceps control was gained 
between weeks 4 and 6.  Once good quadriceps control was gained all patients were 
transitioned to a hinged knee sleeve.  All patients were recommended to abstain from high 
intensity cutting or pivoting activity until at least 12 months post ACI. 
Patient Reported Outcomes 
 The PROs used in this study were the Medical Outcomes Study – 36 Item Short 
Form Health Survey Physical Component Scales (SF-36 PCS),
105, 106, 179
 the Western 
Ontario and McMaster Osteoarthritis Index (WOMAC),
18
 the International Knee 
Documentation Committee (IKDC) Subjective Knee Evaluation Form,
77
 and the Lysholm 
scale.
96
  The SF-36,
58
 IKDC,
58
 Lysholm, 
85
 and WOMAC
58, 85
 have all been evaluated for 
reliability among cartilage patients.  The SF-36 PCS was included to serve as a measure 
of HRQL.  The IKDC and Lysholm are region specific instruments that focus on knee 
function, while the WOMAC is a disease specific instrument focusing on degenerative 
joint disease covering pain, stiffness, and function.  A researcher independent of the 
treating physician reviewed each instrument with the patients and was available to answer 
any questions they may have had.  All PROs were completed at the following time points: 
prior to implantation (preoperation), 3 months, 6 months, and 12 months post-surgery. 
Performance Based Assessments 
 At each time point after completing PROs each participant completed a series of 6 
PBAs in a musculoskeletal laboratory setting.   All PBAs were completed using the 
NeuroCom Balance Master
®
 and long force plate (LFP) (NeuroCom International, 
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Clackamas, OR).   This is a commercially available system designed both as a training 
and evaluation tool for function and balance tasks, and it has the ability to provide 
immediate feedback to clinicians and patients regarding quality of task performance for a 
variety of activities of daily living (ADLs).
5
  
The LFP consists of a 45.72 cm x 152.40 cm force plate with data sampled at 100 
Hz and a personal computer equipped with data capture software (Balance Master ver. 
8.1). These functional tasks were selected because of their direct relationship to activities 
of daily living and the feasibility of patients being able to complete the task at each testing 
time point (Table 2.1). Tests were completed in the order presented at all time points.  
This order was subjectively determined during pilot testing to be from least to most 
demanding. All testing was administered by the same investigator (JSH).  For all single 
limb tests the uninvolved limb was tested first. Three successful trials of each task were 
performed (except for the Weight Bearing Squat which consisted of a single trial at each 
joint angle).  Approximately 15s of rest was permitted between each trial and 30s of rest 
between each task.  For the purposes of this manuscript all outcome variables are 
identified using the names assigned to them by the software utilized. Definitions for these 
variables are presented in Table 2.1. The six tasks are described below.   
Walk Across: Patients walked across the LFP using their freely chosen standard gait speed 
and pattern.  
Weight Bearing Squat: Patients stood still on the force plate at the initial measure was 
recorded with knee flexion angles of 0˚, 30˚, 60˚, and 90˚as tolerated 0˚). They then 
flexed their knees and held positions at 30˚, 60˚, and 90˚as tolerated. The percentage of 
body weight on the involved limb was measured during a single trial with a duration .01s 
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for each position.  A standard goniometer was used to verify knee joint angle at each 
position. 
Unilateral Stance: Patients stood on each leg and maintained their balance for 10 s with 
their eyes open. They begin with the non-weight bearing leg flexed at about 60-80˚ and 
with their hands on their hips. If patients touched down, or their legs touched each other, 
testing was stopped and the trial was discarded. Testing of a condition was discontinued if 
a participant experienced three consecutive failed trials. Testing was repeated for both 
legs with the patients’ eyes closed.   
Sit to Stand: Patients were seated on a 50cm box.  Upon both visual and audio signal from 
the computer they rose to full standing as quickly as possible without using their hands, 
and then maintained a steady stance for the remainder of the 10 s trial.  
Step-Up/Over: Participants stood behind a 29cm high box and stepped up onto the box 
with their test leg, then brought their non-test leg up and over the box, and then stepped 
down with their test leg. This was performed as quickly as possible while still maintaining 
control.  
Forward Lunge: Patients in a standing position stepped forward on one leg and squatted 
down as far as comfortably possible, and then returned to the initial standing position as 
quickly as possible.  
Statistical Analysis 
 Separate repeated measures ANOVAs were used to compare changes in PROs and 
each force plate assessment between preoperative, 3 month, 6 month, and 12 month 
postoperative evaluations.  The significance level was set at p< 0.05 a priori and when a 
main effect for time was evident pairwise comparisons with a Bonferonni adjustment to 
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correct for multiple comparisons were used to identify differences between individual 
time points.  In addition to evaluating for statistical differences, changes between 
performance values at the preoperative time point and each follow-up time point were 
also compared to minimal detectable change (MDC) values.  The MDC values were 
calculated from a concurrent study evaluating the reliability of long force plate measures 
in ACI patients (Chapter 2).
73
  A Pearson product moment correlation was used to 
examine the relationship between PROs and PBAs at each time point.  Relationships with 
R-values above .90 were considered to have a high correlation, 0.71 to 0.90 was 
moderate, and 0.40 to 0.71 was low.
169
  For all correlations a significance level of p ≤ 
0.05 was set a priori.   
 
RESULTS 
 Six participants were declared clinical failures at or before the one year time point 
and were not medically cleared to complete functional testing at all time points.  An 
additional five participants were lost to follow-up.  Finally, one participant failed to 
complete preoperative force plate testing and another participant was lost to follow-up at 
the 6 month time point, but returned to the study at the 12 month time point.  As a result 
full PBA data was only available for 16 subjects.  Full PRO data was available for 21 
patients including 4 patients who were declared failures at the 12 month time point. 
Patient Reported Outcomes 
 There was a main effect for time for all four PRO instruments (Figure 3.1).  There 
were significant improvements from preoperation to 12 month follow-up for the IKDC (p 
= 0.012), SF36-PCS (p = 0.011), Lysholm (p = 0.002), and WOMAC (p = 0.013).  The 
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IKDC (p = 0.50) and the Lysholm (p = 0.008) also improved significantly between 
preoperation and 6 months postoperatively.  There were no significant changes between 
preoperation and the 3 month time point for any of the PRO instruments. 
Figure 3.1. Patient Reported Outcome Scores  
 
*p < 0.05 compared to preoperative time point.  IKDC and Lysholm are scored from 0 to 
100 with 100 representing and ideal score.  SF-36 PCS uses norm based scoring system 
where 50 represents a mean score with a standard deviation of 10 and higher scores 
representing higher levels of function.  The WOMAC is scored 96-0 with 0 representing 
an ideal score. 
Performance Based Assessments 
 The only PBAs to demonstrate changes over time were the Walk Across, Weight 
Bearing Squat, and Step Up/Over (Table 3.1).  There was a significant increase in stride 
length observed between the 3 month and 6 month time points (p = 0.025) for the Walk 
Across task.  There were no significant changes in stride width or walking speed.  For the 
Weight Bearing Squat a main effect for time was observed for squatting at 30⁰, 60⁰, and 
90⁰.  Post-hoc analysis revealed decreases in weight distribution on the surgical limb 
between preoperation (50% body weight) and 3 months (45% body weight, p = 0.05) for
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squatting at 30⁰.  Decreases were also observed between preoperation and 3 months (p = 
0.002) and preoperation and 6 months (p = 0.02) for squatting at 60⁰.   At both the 3 
month time point (43% body weight) and the 6 month time point (44% body weight) a 
lower percentage of body weight was placed on the surgical limb compared to squatting at 
the preoperative time point (50% body weight).  Although not statistically different from 
preoperative values, at the 12 month time point mean weight distribution remained below 
preoperative values at 0⁰ (49 + 3% vs. 48 + 3%), 30⁰ (50 + 3% vs. 46 + 5%), 60⁰ (50 + 
3% vs. 46 + 5%), and 90⁰ (52 + 6% vs. 48 + 4%).  Finally, there were significant 
increases in lift-up force between preoperation (40 + 10% body weight) and 6 months (50 
+ 12% body weight) for the Step Up/Over.  No other Step Up/Over variables changed 
significantly over one year following ACI.  
 Comparison of changes between preoperative and postoperative follow-up values 
to MDC values demonstrated measurable changes in performance for the Walk Across, 
Weight Bearing Squat, Step Up/Over, and Forward Lunge (Table 3.1).  Between 
preoperation and the 3 month time point measurable decreases in weight distribution (7% 
body weight) on the involved limb were observed for squatting at 90⁰.  During the same 
time period increases were observed for lift-up force (8.1% body weight) and 
performance time (0.28s) for the Step Up/Over, and for performance time (0.29s) for the 
Forward Lunge.  Between preoperation and the 6 month time point Walk Across stride 
length increased by 5.2% of body height and Step Up/Over lift-up index increased by 
11.2%.  Finally, between preoperation and the 12 month follow-up Walk Across stride 
length increased by 6% of body height while walking speed increased by 15.1 cm/s and 
Step Up/Over lift-up index increased by 8.16% body weight. 
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Relationship Between Patient Reported Outcomes and Performance Based 
Assessments  
 Across all time points there were 54 significant correlations with absolute R 
values ranging from 0.38 to 0.73.  All significant correlations are presented in Table 3.2.  
Correlations occurred between each of the four evaluated PROs and the Walk Across, 
Unilateral Stance, Weight Bearing Squat, Sit-to-Stand and Forward Lunge functional 
tasks.  At no time point did any of the PROs correlate to outcome measures for the Step 
Up/Over.  Among PBA outcome measures there were 14 measures correlated to the 
IKDC score at varying time points (absolute R value range: 0.38 to 0.61), 18 to SF-36 
PCS score (0.38 to 0.73), 8 to Lysholm score (0.38 to 0.64), and 14 to total WOMAC 
score (0.38 to 0.64).  There were 17 correlations between PRO scores and PBA outcome 
measures at the preoperative time point (0.38 to 0.66), 7 at the 3 month time point (0.45 to 
0.72), 10 at the 6 month time point (0.44 to 0.66), and 20 at the 12 month time point (0.48 
to 0.73).  There were no PRO scores or PBA measures that were consistently correlated to 
each other across all 4 time points.   
 
DISCUSSION 
 The primary purpose of this study was to provide a timeline for recovery that 
could be utilized by both patients and physicians in managing expectations regarding 
postoperative recovery of function. A summary timeline of the functional recovery 
observed in the first year following ACI can be seen in Figure 3.2.  Improvements in 
patients’ self-reported function were observed as early as 6 months following ACI using 
the IKDC and Lysholm outcome scores.  In addition to these PROs, the SF-36 PCS and 
WOMAC also demonstrated improvements one year following ACI.  In contrast, some 
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Table 3.2. Correlations Between Performance Based Assessments and 
Patient Reported Outcomes By Follow-up Time Point  
    Preoperative  3 Months Postoperative 
Task IKDC SF-36 
PCS 
WOMAC Lysholm IKDC SF-36 
PCS 
WOMAC Lysholm 
Walk Across         
 
Width - -0.38 0.50
*
 - - -0.50 - - 
 
Length 0.43 0.47 -0.66
*
 - - - - - 
 
Speed 0.38 - - - - - -0.45 - 
Weight Bearing Squat 
       
 
0 degrees - - - 0.38 - - - - 
 
30 degrees 0.42 - -0.46 0.53
*
 - - - - 
 
60 degrees - - - 0.46 - - - - 
Unilateral Stance        
 
Eyes open 
COG Sway - -0.44 - - - - - - 
 
Eyes closed 
COG SV 
-0.46 - - - - - - - 
Sit-to-Stand         
 
Rise Force - - -0.38 - - - - - 
 
Involved/ 
Uninvolved 
rise 
symmetry 
- 0.40
*
 - - - 0.49 - - 
 
COG Sway - - - - - - - - 
Lunge         
 
Impact Index - 0.45 - - 0.53
*
 0.72
*
 -0.51
*
 - 
 
Distance - - - - - 0.50 - - 
  Time - - - 0.51 - - - - 
All presented correlations are significant at the p < 0.05l level, *p< 0.01) 
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Table 3.2.   (continued) Correlations Between Performance  Based 
Assessments and Patient Reported Outcomes By Follow-up  Time Point  
  6 Months Postoperative 12 Months Postoperative 
Task IKDC SF-36 
PCS 
WOMAC Lysholm IKDC SF-36 
PCS 
WOMAC Lysholm 
Walk Across 
        
 Width - - - - - - - - 
 Length - - - - - - - - 
 Speed - - - - 0.58 0.56 -0.54 - 
Weight Bearing Squat 
     
 0 degrees - - - - - - - - 
 30 degrees 0.44 0.59* -0.52 - - - - - 
 60 degrees - - - - - - - - 
Unilateral Stance 
    
 Eyes open 
COG Sway - - - - -0.54 -0.67
*
 0.64
*
 -0.64
*
 
 Eyes closed 
COG SV 
- - - - -0.59
*
 -0.73
*
 0.58 -0.64
*
 
Sit-to-Stand 
        
 Rise Force - - - - - - - - 
 Involved/ 
Uninvolved 
rise 
symmetry 
- - - - 0.61
*
 0.61
*
 -0.63
*
 0.50 
 COG Sway - - - - -0.51 - - - 
Lunge 
        
 Impact Index 0.62* 0.60* -0.66* 0.61* - - - - 
 Distance 0.45 0.45 -0.51 - - - - - 
  Time - - - - - -0.48 - - 
All presented correlations are significant at the p < 0.05l level, *p< 0.01) 
 
decreases in performance based function relative to preoperative values were seen at the 3 
and 6 month time points with decreased performance values for squatting, lunging, and 
stepping.  Beginning at 6 months, increases in stride speed and length were observed; 
however, the difference between performance time for the involved side relative to the 
uninvolved side was greater at the 12 month time point than at the preoperative time point 
for the Step Up/Over.   Overall, these results suggest that patients may experience 
physical benefits such as decreased pain and symptoms as early as 6 months following 
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ACI, but significant improvement in functional performance of complex tasks such as 
squatting, stepping, and lunging may not occur until 12 months or longer following ACI.    
Figure 3.2. Timeline of Functional Recovery Following Autologous Chondrocyte 
Implantation
 
Patient Reported Outcomes 
PROs have frequently been utilized to report functional outcomes following ACI.    
The observed results suggest that patients should not expect significant improvement prior 
to the 6 month time point, and that in some cases, such as with the WOMAC, 
improvements may not be appreciable until one year post ACI.  The lack of significant 
improvement in PRO scores at the 3 month time point is in agreement with previous 
research by Henderson and Levigne and Ebert et al. 
44, 67
   However,  both of these authors 
observed decreases in self-reported function using the IKDC
67
 and SF-36 PCS
44, 67
 at the 
three month time point, while we observed slight, but non-significant increases.   In 
contrast Tohyama et al. did observe significant improvements in Lysholm scores as early 
as 3 months following treatment with atelocollagen-associated ACI.
171
 
3 Months Post ACI
• No significant 
improvement in self-
reported function
• Increased asymmetry 
of weight 
distribution during 
squatting
• Measurably longer 
time required to 
complete tasks such 
as lunging or going 
up or down steps
• Increased lift-up 
force when stepping 
up onto curbs or 
steps
6 Months Post ACI
• Some significant 
improvements in 
self-reported 
function
• Continued 
asymmetry of weight 
distribution during 
squatting
• Improved stride 
length
• Continued Increases 
in lift-up force when 
stepping up onto 
curbs or steps
• Slowed stepping 
time on involved 
side relative to 
uninvolved
12 Months Post ACI
• Noticeable 
improvement in all 
measures of self-
reported function
• Measurable increases 
in  stride length
• Significant increase 
in speed when 
walking
• Side to side 
differences in 
stepping time are 
greater than 
preoperation with the 
involved side taking 
longer than the 
uninvolved side
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The improvements observed among patients in IKDC, Lysholm, and SF-36 PCS 
scores at 6 months were similar to the outcomes observed by Niemeyer et al. for the 
IKDC
122
 and both Niemeyer et al. and Kreuz et al. for the Lysholm.
89, 122
   Other authors 
have observed even larger improvements in IKDC
171
 and Lysholm
14
 scores as early 6 
months following ACI.  The failure to observe improvements in the WOMAC at the 6 
month time point in the current study is similar to other authors observations of no 
improvement at 6 months in IKDC
67, 89
 or SF-36 PCS
67
 scores.  There have been no 
reports of WOMAC scores for periods of less than 1 year for comparison to the present 
results. 
Across all PROs we observed improvements when preoperative scores were 
compared to scores 12 months following ACI surgery.  These results are in agreement 
with the findings of others when utilizing the IKDC,
42, 65, 67, 89, 121, 122, 158, 186
 Lysholm,
89, 
121, 122, 171, 186
 SF-36 PCS,
67
 and WOMAC
111, 113
 scores 1-year following ACI.  Regardless 
of which outcome instrument is used, the IKDC, Lysholm, SF-36 PCS, or the WOMAC, 
both clinicians and patients can anticipate improvements in self-perceived function during 
the first year following ACI. 
Performance Based Assessments 
 Limited improvements in PBAs were observed 1-year following ACI (Table 3.2.).  
In general, a decrease in physical performance was observed at 3 and 6 months 
postoperatively, followed by a return towards baseline at 12 months following ACI.  This 
pattern of decreased function followed by gradual return of function was particularly true 
for the Weight Bearing Squat, Step Up/Over, and Lunge.  The only measures to show 
positive improvements at or within the 12 month time point were Walk Across stride 
 
 
71 
 
length and speed, and Step Up/Over lift-up index.  These results suggest that 
improvements for simpler, less demanding tasks, such as walking or going up steps can be 
seen as early as 6 to 12 months following ACI.  However, for more complex tasks, 
particularly those that require eccentric quadriceps control - such as squatting, going 
down steps, or lunging - meaningful changes in function may not be observed within the 
first year following ACI.  From the results of this study it is unclear as to whether further 
improvements in function, particularly for more complex tasks occurs over long-term 
follow-up following ACI.  
 Decreases in physical performance at the 3 month time point have been previously 
observed with the 6 minute walk-test following matrix-induced autologous chondrocyte 
implantation (MACI)
44, 45
 and characterized chondrocyte implantation (CCI).
146
  Similar 
to our results, other researchers have observed slight improvements in walking 
performances at the 6 month
45
  and 12 month
45, 146
 time points that continue to improve at 
24 month follow-up.
45, 146
  During laboratory gait analysis improvements in gait speed and 
stride length, without significant changes in stride width, were observed over 12 months 
following MACI.
43
  These results support our observation that, after an initial decrease in 
function, both patients and physicians can anticipate improvements in gait beginning 
around the 6 month time point following ACI. 
 In examining more dynamic tasks, Van Assche et al. observed deceased functional 
performance for a series of hopping and strength tasks (single-limb hop, cross-over hop, 6 
m timed hop, and isometric knee extension strength) at 6 months following CCI and no 
significant improvements were observed as late as 24 months after CCI.
172
  For example, 
these authors observed a 9% decrease in the single-leg hopping limb symmetry index 
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through 24 months following surgery.
172
  These results are in agreement with our 
observations demonstrating an initial decrease in function for more dynamic tasks such as 
squatting, stepping, and lunging with few or no significant or measurable improvements 
in functional performance at the 12 month time point following ACI.   
 Normative values for some LFP variables for the Weight Bearing Squat, 
Unilateral Stance, Step Up/Over, and Forward Lunge have been published by the system 
manufacturer.
3
  This normative data is presented by age group with individuals ages 20 to 
39 (n = 74) and individuals ages 40 to 59 (n = 47) being the most appropriate groups for 
comparison to the current cohort.  In comparing values observed in the present study to 
this historical data from healthy individuals some general observations can be made.  For 
the Weight Bearing Squat normative data is only available for the standing (0⁰) position.  
Normative values for weight asymmetry in this position ranged from 0.6 ± 3.1% to 1.4 ± 
3.1% body weight.  These values were similar to those seen for ACI patents with 
asymmetries ranging from 0.7 ± 3.0 % (at 6 months) to 2.4 ± 2.3% (at 3 months).  For the 
Unilateral Stance the values observed among ACI patients throughout treatment for both 
the eyes open (0.8 ± 0.2 to 0.9 ± 0.3 deg/s) and closed (1.8 ± 0.6 to 3.0 ± 3.5 deg/s) 
conditions were similar to those observed among both normative age groups (eyes open: 
0.7 ± 0.1 to 0.9 ± 0.3, eyes closed 1.9 ± 0.7 to 2.9 ± 1.1 deg/s).  For the Step Up/Over lift 
up index preoperative values (39.8 ± 10.3% body weight) began below normative values 
(46.9 ± 14.1 % body weight to 50.2 ± 15.5 % body weight) but rose to normative values at 
all follow-up time points ranging from 47.9 ± 12.1% body weight at 3 months to 50.0 ± 
12.1% body weight at 6 months.  Similar values were also observed between ACI patients 
and healthy norms for Step Up/Over impact index.  However, normative data for Step 
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Up/Over time (1.20 ± 0.2s to 1.3 ± 0.3s) trended to be lower than ACI patients at any time 
point (1.4 ± 0.3s to 1.7 ± 0.7s).  For the Forward Lunge, impact index (21.8% ± 6.5% 
body weight to 24.4 ± 7.4 % body weight) was lower at all testing points compared to the 
normative data (36.0 ± 14.6% body weight to 42.2 ± 15.3 % body weight).  Also, Forward 
Lunge contact time was slower in ACI patients (1.2 ± 0.4s to 1.5 ± 0.6s) than has been 
previously reported among healthy individuals (1.0 ± 0.2s to 1.1 ± 0.2s).  One variable 
that did approach normative values (48.3 ± 8.6% height to 53.4 ± 7.8% height) was 
Forward Lunge distance which increased from 45.8 ± 7.1% height at preoperation to 48.3 
± 5.9% height at the 6 month time point. 
 In comparison to normative data
3
 it can be observed that some LFP variables were 
normal at baseline and return to that level by the 12 month time point.  These include the 
Weight Bearing Squat at 0⁰, Single limb stance, and Step Up/Over impact index.  Other 
variables including the Step Up/Over lift-up index and Forward Lunge distances are 
below normative values preoperatively but increase to normal ranges by 12 months 
postoperative.  Finally, some variables are below normal ranges preoperatively and 
remain so at the 12 month time point.  These include the Step Up/Over time and Forward 
Lunge time and impact index. 
 Across the literature and within our study sample, improvements in gait relative to 
the preoperative time point have been observed as early as 6 months following ACI.  
However, improvements in more dynamic activities such as squatting, lunging, stepping, 
and hopping have not been observed within the first 12 months following ACI in the 
present study or elsewhere.  These results support existing theory that although 
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improvements in self-report measures may occur early postoperatively, maximal defect 
healing and functional improvement continues beyond 12 months following ACI. 
22, 90, 145
 
Relationship Between Patient Reported Outcomes and Performance Based 
Outcomes 
 Low to moderate correlations were observed between various PROs and PBAs at 
each of the 4 time points with no PRO/PBA pairing correlating consistently across all 
time points.  The limited relationships observed between PROs and PBAs among ACI 
patients is similar to that which has been previously reported among patients with other 
lower extremity pathologies.  Among anterior cruciate ligament patients (ACL)
120, 144
 
IKDC scores have been observed to have little (R=.28) 
159
 to no
82
  relationship to single-
leg hop, triple hop, cross-over triple hop, or vertical jump performance.  Similarly, the 
Lysholm has been observed to have a low (R = 0.36)
159
 to non-significant
52, 120
 correlation 
to the single-leg hop or figure 8 run among ACL patients.  In a longitudinal study of total 
knee patients Mizner et al. observed low and variable correlations (R= -0.07 to -0.29) 
between the SF-36 bodily pain subscale and performance on the six-minute walk test, 
timed up and go test, and stair climbing test.
117
  These patients were evaluated 
preoperatively and 1 month and 12 months postoperatively.   Similar to the present study, 
none of the correlations between the SF-36 bodily pain scale and the performance 
measures were consistently significant across time points.
117
  Finally, in the only other 
study reporting the relationship between a LFP assessment and a PRO, Jacobs et al. did 
not observe a significant relationship pre or postoperatively between a modified Step 
Up/Over lift-up index and Knee Society pain or function scores.
79
  Despite our attempts to 
select PBAs that included activities addressed in the PROs (Ex. walking, going up and 
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down steps, rising from sitting, and squatting) no consistent relationships were observed 
between these two methods of assessing function. 
Overall the results of this study suggest poor concurrent validity between PROs 
and PBAs.  It has been proposed that PRO instruments may be disproportionately 
influenced by pain,
79, 97, 165, 166
 and this is one possible explanation for the slight trend of 
improvement in PRO scores observed as early as 3 months (Figure 3.1) despite significant 
decreases in physical function.  These findings are in agreement with the work of Mizner 
et al.
117
 and Parent and Moffett
134
 both of which observed that in the acute phase of 
recovery following total knee arthroplasty patients subjectively over estimated their 
functional capabilities.  Similar to the present study, improvement or no change in PRO 
scores was observed during early postoperative follow-up despite concurrent decreases in 
objective measures of physical performance.
117, 134
  
The variability of the correlations across time in this study and elsewhere is 
particularly important and suggests that different latent variables may contribute to the 
self-appraisal process used to complete PRO forms at varying times during clinical 
follow-up.  These variations in appraisal criteria are in agreement with response shift 
theory which proposes that over time changes in personal evaluation standards and 
perspective may result in changes to self-evaluation scores independent of true physical 
changes in function.
139, 163
  One proposed solution to the disconnect between PROs and 
PBAs is that patients complete some form of PBA prior to completing PROs.
40
  This 
methodology provides patients with an additional sample of experiences from which to 
evaluate their physical capabilities and may improve the accuracy of the self-appraisal 
process.
139
  In the present study we chose to have patients complete all PROs prior to 
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testing PBAs.   This was done so that PBA performance would not influence PRO scores, 
and our results could be compared to other ACI outcome studies which to date have 
predominantly utilized PRO scores as primary outcome measures and have rarely 
included PBAs.  However, our results support the use of both forms of assessment when 
evaluating changes in function following ACI.  Furthermore, future research should 
consider evaluating PBAs prior to having patients complete PROs to possibly improve 
PRO accuracy and better describe post-operative changes in function.  
Limitations 
 A limitation of this study is the inclusion of a diverse ACI patient population.  The 
study sample included individuals undergoing treatment for lesions to the patella, 
trochlea, and/or femoral condyle many of which also underwent concomitant realignment 
procedures.  Because of this variability, the presented timeline for recovery is not specific 
or precise for any one defect location and/or realignment procedure.  Instead a broad 
pattern of recovery has been presented that can be generalized to a variety of defect 
patterns and sizes. 
 An additional limitation of this study is the lack of outcomes beyond 12 months 
post-ACI.  However, the purpose of this study was to provide a descriptive time line for 
changes in self-perceived function and functional recovery in the first year following ACI.  
This time line is intended to describe when patients can expect improvements in activities 
of daily living and when patients will perceive a benefit from the surgery, two key pieces 
of information that may be valuable to patients and physicians when deciding if and when 
to undergo ACI.  Future examination of these outcome variables for a longer period (> 1 
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year) will provide more information regarding the long term course of recovery following 
ACI.   
 
CONCLUSIONS 
 This study presents a descriptive timeline for changes in both PROs and PBAs 
during the first 12 months following ACI and also describes the relationship between 
PRO and PBA scores.  Self-perceived changes in function were observed as early as 6 
months following ACI while performance based measures of function demonstrated 
functional deficits compared to preoperative levels at both the 3 and 6 month time points.  
Specifically, patients demonstrated increased asymmetry of weight distribution when 
squatting and longer performance times for lunging and stepping activities.  At the 12 
month time point performance improvements were seen for walking speed and stride 
length: however, Step Up/Over time and Forward Lunge impact index and time remained 
below previously reported norms.  Overall, it was observed that patients’ perceptions of 
functional improvements may outpace true physical changes in function.  This 
observation was further supported by the limited and inconsistent correlations existing 
between PROs and PBAs.  These results suggest that the relationship between patient’s 
self ratings and physical abilities may vary over time and be largely influenced by 
independent factors. Therefore, both PROs and PBAs should both be utilized to 
comprehensively assess outcomes following ACI. 
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CHAPTER 4: INFLUENCE OF RESPONSE SHIFT ON PATIENT REPORTED 
OUTCOMES FOLLOWING AUTOLOGOUS CHONDROCYTE IMPLANTATION 
 
INTRODUCTION 
A variety of outcome measures are frequently used in clinical research to 
document treatment effectiveness.  While it may be possible to document changes in 
clinical measures such as strength or range of motion, it is difficult to quantify abstract 
concepts such as function or health related quality of life (HRQL).  To assess function or 
quality of life, patients are often asked to evaluate their well-being using a self-report 
instrument or questionnaire to document patient reported outcomes (PROs).  PROs are 
used to document temporal changes such as between pre- and post-treatments.  However, 
PROs may be influenced by response shift.
155
  Response shift is the phenomenon by which 
an individual’s self-evaluation of a construct changes due to a change in internal 
standards of measurement (recalibration), a change in values or priorities 
(reprioritization), or a personal redefinition of the target construct 
(reconceptualization).
163
  Response shift may interfere with the ability to detect change in 
a construct with accuracy.  Examples of response shift are observed among the terminally 
ill where patients’ physical health deteriorates, yet their self-reported HRQL remains 
stable.
156, 162, 181
  It has been hypothesized that these changes may be a result of changing 
values, standards and priorities.
155
  For example, patients become more focused on time 
with family than work productivity.  Response shift has been documented in cases of 
terminal and chronic disease or illness.
60, 170, 178, 181
  Only three known studies have 
examined response shift in an orthopedic population.
10, 141, 142
  In two response shift was 
observed among knee arthroplasty patients 6 months and 12 months postoperatively.
141, 
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142
  In the third, response shift was observed among articular cartilage patients undergoing 
microfracture treatment.
10
  Based on these results, it is possible that patients undergoing 
knee surgery for localized articular cartilage damage may also experience response shift.   
Treatment of articular cartilage injuries represents a complex and challenging 
problem for both orthopedic surgeons and rehabilitation specialists.  If not treated 
appropriately, defects to the hyaline cartilage can become increasingly painful and 
disabling.  This is particularly true for lesions of the knee where biomechanical stresses 
result in both shear and compressive forces during normal activities of daily living.
38
  
Chondral lesions have been observed in as many as 63% of knee arthroscopies; therefore, 
effective treatment and rehabilitation is important.
39
  One of the emerging forms of 
treatment for chondral defects is the use of cultured chondrocytes in the procedure known 
as autologous chondrocyte implantation (ACI).
28
 
In the twenty years since its conception ACI has been performed on thousands of 
patients with degenerative and traumatic cartilage lesions.
61
  While early results for ACI 
outcomes are promising, the existing literature primarily reports outcomes using PROs.
21, 
29, 31, 44, 49, 51, 86, 90, 98, 108, 115, 116, 149, 185
  Although PROs are used frequently in orthopedic 
and rehabilitation literature, the traditional pre-post-test research designs used may be 
influenced by response shift phenomenon.  If the PROs frequently used to evaluate ACI 
outcomes are subject to a response shift, then reported outcomes may under- or over-
estimate the effectiveness of existing articular cartilage treatments.  The extended 
preparation and rehabilitation required for ACI may make patients undergoing this 
procedure particularly prone to response shift.  ACI is a two step surgical procedure.  
During the first surgery a cartilage biopsy is obtained from which cells are cultured and 
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then a minimum of 4 weeks later implanted into the defect during a second surgery.
28
  In 
many cases patients have a history of prolonged knee pain and multiple previous surgeries 
prior to undergoing ACI.  After undergoing ACI, current rehabilitation protocols 
recommend patients remain non-weight bearing for 6 to 12 weeks and maximum 
improvements may not be seen until 1-2 years following surgery.
143
  It is possible that this 
extended period of functional limitations, combined with the inherent expectations 
associated with surgery, may result in a response shift. 
It has been recommended that performance based assessments (PBAs) be included 
in response shift studies to provide an additional reference of physical function.  Schwartz 
et al. suggests that differences in performance based measures and self-evaluations may 
represent response shifts experienced by individuals in response to physical or emotional 
changes in health.
157
  There is limited to no documentation of PBAs in the previous 
literature regarding response shift among orthopedic knee patients.
141, 142
  
Accurate documentation of change is vital to evaluating patient progress. If 
methods of documenting change do not accurately reflect the constructs they claim to 
measure then interventions intended to address those constructs cannot be accurately 
evaluated.  If PRO instruments used to evaluate function in ACI patients are influenced by 
a response shift, then reported changes in function over time may be inaccurate.  The 
purpose of this study is to determine if patients undergoing ACI experience response shift.  
It was proposed to verify a response shift via the then-test method and comparison to 
objective PBAs.  It was hypothesized that there will be evidence of a response shift using 
the following PROS: the Medical Outcomes Study – 36 Item Short Form Health Survey 
Physical Component Scale (SF-36 PCS), the Western Ontario and McMaster 
 
 
81 
 
Osteoarthritis Index (WOMAC), and the International Knee Documentation Committee 
(IKDC) Subjective Knee Evaluation Form.  It was also hypothesized that outcomes 
evaluated by the Lysholm Knee Scale (Lysholm) would not be influenced by response 
shift.  The IKDC, WOMAC, and SF-36 rely heavily on subjective evaluations of quality 
of task performance, physical function, and pain levels which may be influenced by 
reprioritization, recalibration, and reconceptualization.  Therefore, it is anticipated that 
these scales will be influenced by response shift.  For example, the perception of mild 
pain for someone who has had chronic pain may be recalibrated following surgical 
intervention.  It is not anticipate that the Lysholm scale will demonstrate a response shift 
because of its focus on the capacity to perform specific tasks rather than the ease or pain 
associated with task performance. 
 
METHODS 
Patients 
Patients were prospectively recruited from an active cartilage center.  Inclusion 
criteria were the following: planned ACI surgery to the medial or lateral femoral condyle, 
trochlea, or patella; willingness to participate and no uncorrectable contraindications to 
ACI such as extensive degenerative joint disease, insufficient meniscus or unstable knee.  
There were no exclusions based on limb malalignment if the malalignment was corrected 
prior to or at the time of surgery via high tibial osteotomy or tibial tubercle transfer.  
Similarly, patients undergoing concomitant or staged ligament reconstruction to correct 
joint instability were also eligible for study participation.  Patients undergoing 
concomitant meniscal transplant were excluded. 
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A total of 29 patients (17 males, 12 females, 36.3 ± 6.9 yrs, 174.4 ± 9.6 cm, 90.4 ± 
19.4 kg)  agreed to participate.  Three patients declined to participate resulting in an 
enrollment rate of 90%.  Of the enrolled patients 13 underwent ACI to the patellofemoral 
joint with a tibial tubercle transfer and the remaining 16 underwent ACI to the femoral 
condyle, of which 4 also had a concomitant high tibial osteotomy.  The mean number of 
defects treated per patient was 1.38 ± 0.6 with an average treatment area of 6.6 ± 2.5 cm2 
(range 2.3 to 13.0 cm
2
) as measured intraopteratively.   All participants signed a 
university approved IRB consent form. 
Surgical Procedures and Rehabilitation 
 All patients underwent a two-step ACI procedure performed by the same surgeon 
(CL).  During the first procedure a limited chondroplasty was performed and the lesion 
was evaluated arthroscopically.  At this time a biopsy was obtained from the intracondylar 
notch (100 to 200mg cartilage).  This sample was sent to a commercial laboratory where 
it was cultured and expanded (Carticel, Genzyme Corp, Cambridge, MA).  In a second 
surgical procedure chondrocyte implantation was performed using a mini-
arthrotomy.  First the defect or defects were prepared using a curette to debride down to 
the subchondral plate with stable edges.  A type I/III collagen membrane (Chondro-
Gide 
(R)
 , Geistlich Biomaterials, Wohousen, Switzerland) was shaped to match the 
defect.  Sutures and fibrin glue (Tisseel, Baxter Healthcare Corp., Deerfield, IL) were 
used to adhere the membrane over the defect to form a water tight seal.  The chondrocytes 
in suspension were then injected beneath the membrane into the defect through a small 
portal remaining at the edge of the collagen membrane.  The portal was then closed and 
sealed with sutures and additional fibrin glue. 
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 All patients followed standardized rehabilitation protocols following surgery.
93
  
All patients were braced in full extension and were non-weight bearing for 2 weeks 
postoperatively.  Toe-touch weight bearing was permitted from 2 to 4 weeks with partial 
weight bearing from 4 to 6 weeks and progression to full weight bearing between weeks 6 
to 12.  Continuous passive motion was prescribed for all patients for 6 to 8 hours per day 
for 6 weeks.  For defects in the tibiofemoral joint, knee braces were gradually unlocked 
between 2 to 4 weeks as quadriceps control was gained.  For defects to the patellofemoral 
joint, knees were braced in full extension for weight bearing through 4 weeks 
postoperative and then were gradually unlocked as quadriceps control was gained 
between weeks 4 and 6.  Once good quadriceps control was gained all patients were 
transitioned to a hinged knee sleeve.  All patients were recommended to abstain from high 
intensity cutting or pivoting activity until at least 12 months post ACI. 
Outcome Measures 
Patient Reported Outcomes 
The PROs used in this study were the SF-36 PCS,
105, 106, 179
 the WOMAC,
18
 the 
IKDC,
77
 and the Lysholm.
96
  The SF-36,
58
 IKDC,
58
 Lysholm, 
85
 and WOMAC
58, 85
 have 
all been evaluated for reliability among cartilage patients.  The SF-36 PCS was included 
to serve as measures of health related quality of life (HRQL).  The IKDC and Lysholm 
are region specific instruments that focus on knee function, while the WOMAC is a 
disease specific instrument focusing on degenerative joint disease covering pain, stiffness, 
and function.  Reliability has been previously established for all of these instruments.
18, 77, 
85, 103, 105, 147
  A researcher independent of the treating physician reviewed each instrument 
with the patients and was available to answer any questions they may have had.  All PROs 
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were completed at the following time points: prior to implantation, 6 months, and 12 
months post-surgery. 
Performance Based Assessments 
 At each time point after completing PROs each participant completed a series of 6 
PBAs in a musculoskeletal laboratory setting.   All PBAs were completed using the 
NeuroCom Balance Master
®
 and long force plate (LFP) (NeuroCom International, 
Clackamas, OR).   This is a commercially available system designed both as a training 
and evaluation tool for function and balance tasks, and it has the ability to provide 
immediate feedback to clinicians and patients regarding quality of task performance for a 
variety of activities of daily living (ADLs).
5
  
The LFP consists of a 45.72 cm x 152.40 cm force plate with data sampled at 100 
Hz and a personal computer equipped with data capture software (Balance Master ver. 
8.1, NeuroCom International, Clackamas, OR). These functional tasks were selected 
because of their direct relationship to activities of daily living and the feasibility of 
patients being able to complete the task at each testing time point (Table 2.1). Tests were 
completed for both testing sessions in the order presented in Table 2.1, which was 
determined to be from least to most demanding based on patient reporting of difficulty 
during pilot testing. All testing was administered by the same investigator (JSH). For all 
single limb tests the uninvolved limb was tested first. Three successful trials of each task 
were performed, except for the Weight Bearing Squat which consisted of a single trial at 
each joint angle and the Rhythmic Weight Shift which consisted of one trial at each speed 
in each direction.  Approximately 15s of rest was provided between each trial and 30s of 
rest between each task.  For the purposes of this manuscript all outcome variables are 
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identified using the names assigned to them by the software utilized. Definitions for these 
variables are presented in Table 2.1. The six tasks are described below.   
 
Walk Across: Patients walked across the LFP using their freely chosen standard gait speed 
and pattern.  
Weight Bearing Squat: Patients stood still on the force plate and the initial measure was 
recorded with knee flexion angles of 0˚, 30˚, 60˚, and 90˚as tolerated 0˚). They then flexed 
their knees and held positions at 30˚, 60˚, and 90˚as tolerated. The percentage of body 
weight on the involved limb was measured during a single trial with a duration .01s for 
each position.  A standard goniometer was used to verify knee joint angle at each position. 
Unilateral Stance: Patients stood on each leg and maintained their balance for 10 s with 
their eyes open. They begin with the non-weight bearing leg flexed at about 60-80˚ and 
with their hands on their hips. If patients touched down, or their legs touched each other, 
testing was stopped and the trial was discarded. Testing of a condition was discontinued if 
a participant experienced three consecutive failed trials. Testing was repeated for both 
legs with the patients’ eyes closed.   
Sit to Stand: Patients were seated on a 50cm box.  Upon both visual and audio signals 
from the computer they rose to full standing as quickly as possible without using their 
hands, and then maintained a steady stance for the remainder of the 10 s trial.  
Step-Up/Over: Participants stood behind a 29cm high box and stepped up onto the box 
with their test leg, then brought their non-test leg up and over the box, and then stepped 
down with their test leg. This was performed as quickly as possible while still maintaining 
control.  
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Forward Lunge: Patients in a standing position stepped forward on one leg and squatted 
down as far as comfortably possible, and then returned to the initial standing position as 
quickly as possible. 
Assessment of Response Shift 
 A variety of methodological and statistical approaches have been proposed for the 
measurement of response shift using self-report instruments. 8, 56, 71, 88, 109, 130, 131, 153    One 
of the most common approaches is the Then-test Method (Figure 4.1).
70, 71
 This approach 
is identical to a traditional pre-test/post-test method with the exception that subjects 
complete an additional “then-test” assessment at the same session as their post-test 
assessment.  For the then-test subjects are instructed to assess how they were at the time 
of the pre-test, prior to the intervention.  The rationale for this design is that subjects will 
provide responses from the same frame of reference and calibration standards to both the 
then-test and the post-test by completing them at the same time.  In a pre/post design 
traditional change (TC) is the difference between post-test and pre-test scores and is the 
only variable of interest.  With the then-test method, response shift is calculated as the 
difference between the then-test and the pre-test and the response shift adjusted change 
(RSAC) is considered to be the difference between the post-test and the then-test.   
A limitation of the then-test method is that a response shift will only be detected 
on the group level if the direction of the response shift experienced is the same for the 
majority of patients.  A group effect for response shift has the potential to influence 
overall study interpretation and may result in over or under reporting of outcomes when 
only traditional change is examined and response shift is not taken into consideration.  
Because numerous personal and environmental factors can influence patient perspective, 
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it may be necessary to evaluate effects of response shift at the individual level.  On an 
individual level, response shift can influence HRQL and may be clinically relevant to the 
care and management of individual patients.
72
  This may be particularly true in the case of 
cartilage patients where few diagnostic tools are readily available to evaluate the healing 
process, and subjective reporting of symptoms and perceived progress are the primary 
clinical indicators of treatment outcome.  In the present study response shift will also be 
examined on the individual level by evaluating the magnitude of the response shift 
occurring without regard for the direction.   
Figure 4.1. Then-Test Method for Assessing Response Shift
 
For the then-test method patients are requested to complete an outcome instrument three 
times. First pre-treatment (Pre-test), again at a specified post-treatment time point (Post-
test), and at that same post-treatment time point they also complete a Then-test on which 
they are asked to retrospectively rate how they were at the pre-treatment time point. From 
these three scores response shift, response shift magnitude, traditional change, and 
response shift adjusted change can then be calculated.  
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Statistical Analysis 
Main Outcome Measures 
The dependent variables of Response Shift, Response Shift Magnitude, Traditional 
Change and Response Shift Adjusted Change were calculated for the IKDC, Lysholm, SF-
36 PCS and WOMAC at 6 months and 1 year following ACI as described in Figure 4.1.   
Group Effect 
 To investigate the occurrence of a group level response shift paired t-tests were 
used to compare then-test scores to pre-test scores for each instrument and to compare TC 
to RSAC for each instrument.  Significant t-test results would support the occurrence of a 
group effect with a consistent response shift occurring across patients.  A large difference 
between scores would support the importance of accounting for the effects of response 
shift and its potential influence on the over or under reporting of treatment effects with 
traditional pre-post outcomes. 
Proposed Statistical Tests to Validate Occurrence of a Group Level Response Shift 
Pearson product moment correlations between PROs and PBAs were used to 
evaluate the relationship between pre-test, post-test, and then-test scores for any PRO for 
which a group level response shift was evident.  For each PBA variable (Table 4.1) for 
which a significant correlation was observed separate regression equations were 
calculated to predict pre-operative PBAs from pre-test PROs and then-test PROs, and to 
predict post-operative PBAs from post-test PROs.  Parameter estimates (β) were then 
compared using 95% confidence intervals.  This process was completed at both the 6 and 
12 month time points.  A significant change in the relationship between self-evaluation 
(PROs) and physical performance (PBAs) was considered evidence to verify that a 
response shift had occurred.  Because post-test PROs and then-test PROs were completed 
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at the same time point postoperatively, it was anticipated that these tests would relate 
similarly to PBAs (Ho: βPost = βThen).  In contrast, pre-test PROs were completed prior to 
surgery, prior to the occurrence of a potential response shift, resulting in a different frame 
of reference and a different relationship to PBAs (Ho: βPre ≠ βPost, and βPre ≠ βThen). 
 
Table 4.1. Linear Regressions Proposed to Verify Occurrence of a Response Shift 
 
 
 
 
 
 
 
Individual Effect 
 To investigate the occurrence of an individual level effect for response shift, 
response shift magnitude was calculated as the absolute value of the response shift for 
each PRO.  One-sample t-tests were then used to compare the response shift magnitude to 
previously established minimal detectable changes (MDCs) for each PRO instrument.  
The MDC at 6 and 12 month follow-up has been previously established among patients a 
minimum of 5 years post ACI for the IKDC (15.6 points at 6 months, 13.7 points at 12 
months), WOMAC (10.9, 15.3), and SF-36 PCS (3.2, 3.6).
58
  For the Lysholm scale an 
MDC of 15.8 was calculated from previously published reliability and ICC values among 
patients awaiting surgery for chondral defects.
15, 85
 Pearson product moment correlations 
Regression Equations 
(1) yPBA(pre) = β01 + β1xPRO(pre)  
(2) yPBA(post6) = β02 + β2xPRO(post6)  
(3) yPBA(post12) = β03 + β3 xPRO(post12) 
(4) yPBA(pre) = β04 + β4xPRO(then6) 
(5) yPBA(pre) = β05 + β5xPRO(then12)  
Performance Based Assessment (PBA), Patient Reported 
Outcome (PRO), Preoperative (Pre), 6 Months 
Postoperative (Post6), 12 Months Postoperative (Post12), 
Then-Test 6 Month Postoperative (Then6), Then-Test 12 
Months Postoperative (Then12) 
 
 
90 
 
were used to evaluate the relationship between response shift (Then-test – Pre-test) and 
TC to determine if change in self-perceived level of function influenced response shift. 
 
RESULTS 
 Six participants were declared clinical failures at or before the one year time point 
and were not medically cleared to complete functional testing at all time points.  An 
additional five participants were lost to follow-up.  Finally, one participant failed to 
complete preoperative force plate testing and another participant was lost to follow-up at 
the 6 month time point, but returned to the study at the 12 month time point.  As a result 
full PBA assessment data was only available for 16 subjects.  At the 12 month time point 
full PRO data was available for 22 patients including 4 patients who were declared 
failures at that time point.  At the 6 month time point full PRO data was available for 23 
patients including 2 who were declared failures at or prior to that time point. 
Group Level Analysis 
 Main outcome measures are reported in Table 4.2.  No group level effect for 
response shift was observed.  There were no differences between Pre-test and Then-test 
scores for any of the PROs evaluated.  There were also no differences between RSAC and 
TC, and none of the mean RS values exceeded previously established MDC values for the 
IKDC, Lysholm, SF-36 PCS, or WOMAC.  Because there was no evidence of a group 
level response shift for any of the PROs, the proposed analyses involving correlation and 
regression to verify response shift with functional performance were not completed.  
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Individual Level Analysis 
RSM values were used to determine the number of subjects that experienced a 
response shift beyond the MDC at the 6 and 12 month time points for each PRO 
instrument.  At 6 months it was observed that there was a response shift beyond the MDC 
for 8 patients assessed via the IKDC, 6 patients for the SF-36 PCS, 8 patients for the 
Lysholm, and 15 patients for the WOMAC.  At the 12 month time point 6 patients for the 
IKDC, 9 patients for the SF-36 PCS, 9 patients for the Lysholm, and 8 patients for the 
WOMAC experienced response shifts that exceeded the MDC. Overall 8 patients at 6 
months and 4 patients at 12 months demonstrated evidence of a response shift on at least 
3 of the four instruments utilized.  The only PRO to show a significant response shift at an 
individual level across patients was Total WOMAC score at 6 months.  The mean RSM 
value for the WOMAC at 6 months was 17 ± 13 which was significantly greater than the 
MDC over 6 months of 10.9 established by Greco et al.
58
 
Finally, there were no significant correlations between TC values or RS values at 
6 or 12 months for any of the PROs evaluated.  These results suggest that the occurrence 
of a response shift is not related to overall treatment outcome as traditionally evaluated by 
PROs.  
 
DISCUSSION 
Group Level Effects 
 The purpose of this study was to evaluate 4 common PRO instruments for 
evidence of response shift in patients following ACI.  Had any of those PROs 
demonstrated evidence of a group level response shift, linear regression analysis would 
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have been used to validate the occurrence of this response shift via comparison of self-
report and performance based outcome measures.  An example of this proposed method 
of analysis can be seen in Appendix B.  There were no group level effects for response 
shift observed for the IKDC, Lysholm, SF-36 PCS, or WOMAC.  These results fail to 
support the hypothesis that response shift would be evident for the IKDC, SF-36 PCS, and 
WOMAC, but the results do support the hypothesis that no response shift would be 
observed for the Lysholm. 
 Previous research in both microfracture
10
 and total knee arthroplasty
141, 142
 has 
reported the occurrence of a statistically significant response shift among patients.  A 
significant difference between pre-test and then-test scores for the WOMAC
141, 142
 and the 
SF-36 PCS
141
 has been reported  at 6 and 12 months following knee arthroplasty.  
Similarly, a response shift was reported using the Lysholm scale among patients a median 
of 34 months following microfracture for knee articular cartilage damage.
10
  In both 
patient populations a positive response shift was observed, meaning that patients 
retrospectively rated their preoperative function lower on the then-test than they did at the 
original preoperative evaluations,
10, 141, 142
 as a result RSAC demonstrated greater 
improvement in function than TC for at least two studies.
141, 142
 
 Upon initial review our failure to observe a group level response shift is in 
disagreement with the previous work
10, 141, 142
 in orthopaedic knee patients.  However, 
upon further examination the values observed in the present study are very similar to 
those reported elsewhere.  In the present study mean RS values of -6 ± 18 and -12 ± 29 for 
the Lysholm were observed compared to a median RS of -7 (interquartile range 4 to -17) 
by Balain et al.
10
  Similarly, mean RS values of 5 ± 21 and -3 ± 19 were observed for the 
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WOMAC and 0.94 ± 8.97 and 2.28 ± 9.08 for the SF-36 PCS, compared to mean 
WOMAC RS values of 3.79 ± 19.52, 5.45 ± 16.85 and 6.73 ± 15.50 and SF-36 PCS 
values of -1.66 ± 8.05 and -3.16 ± 7.94 reported by Razmjou et al.141, 142  In all cases the 
mean or median differences between then-test and pre-test scores were less than the 
previously established MDC scores for each instrument and standard deviations or 
reported ranges were quite high.  However, the larger samples sizes in the previous 
studies, ranging from 53
10
 to 234,
141
 resulted in statistically significant RS values, leading 
the authors to conclude that a response shift had occurred.  By examining actual mean RS 
values and standard deviations it can be concluded that the group effect for response shift 
observed in previous studies was no more clinically meaningful than those observed in the 
present study.  This conclusion was reiterated by the previous authors who conceded that 
although a statistically significant response shift had occurred, adjusting for the response 
shift did not change clinical conclusions regarding treatment efficacy.
10, 141, 142
  Based on 
the present study and previous reports, a slight group effect for response shift may occur 
among postoperative orthopaedic knee patients; however, this response shift is not 
substantial enough on a group level to invalidate the use of traditional pre-post outcomes 
assessment methods.  
Individual Level Effect 
 No significant group level effect was observed for any of the PRO instruments 
included in this study.  However, by comparing RSM values to previously established 
MDC values for articular cartilage patients a statistically significant response shift (p = 
0.039) was observed on an individual level for the WOMAC at 6 months. This result 
means that although WOMAC scores did not demonstrate a group level effect for 
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response shift with the majority of patients recalibrating their then-test scores in a uniform 
direction, the mean magnitude of change (RSM) observed on WOMAC scores did exceed 
MDC values.  In this study’s population, individual patients did exhibit a response shift.  
However, some patients’ then-test scores recalibrated positively (Then test>Pre-test) 
while others shifted negatively (Then-test< Pre-test) as a result mean RS values were not 
statistically significant, but RSM values were.  RS variability in magnitude and direction 
were substantial enough that there was no difference in TC and RSAC values and 
accounting for response shift did not alter clinical interpretation of treatment outcomes on 
the group level.  However, RSM values suggest that WOMAC scores are susceptible to 
response shift on the individual patient level.  If WOMAC scores are being used to track 
treatment progress of an individual patient, response shift should be taken into 
consideration. 
Additional analyses using MDC values suggested that some individual patients may 
experience a clinically relevant response shift across PRO instruments with 8 patients at 6 
months and 4 patients at 12 months observed to have RSM values exceeding MDC values 
on at least 3 out of 4 PROs.  Utilizing RSM values instead of RS values provides a 
depiction of the magnitude of response shift which can be examined without regard for 
the direction of the response shift.  The direction of the response shift is important on a 
group level to evaluate the influence of response shift on interpretation of overall 
treatment effects across patients.  However, because it is clear that patients may 
experience either a positive or negative response shift, averaging RS values across 
patients may obscure the occurrence of a true, albeit non-uniform, response shift.   
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 MDC values and minimal clinically important differences (MCID) were also 
utilized in previous assessments of response shift in orthopaedic knee patients.  Razmjou 
et al. observed that 36% of patients experienced a response shift that exceeded MCID 
values (15 points) for the WOMAC.
141
  In the present study it was observed that 65% of 
patients experienced a response shift that exceeded the 6 month MDC (10.9) for the 
WOMAC in articular cartilage patients.  At 12 months 38% of patients experienced a 
response shift exceeding the 12 month MDC (15.3) for the WOMAC.  Both the present 
study and previous research
141
 suggest that on an individual level the WOMAC may be 
subject to both meaningful and measurable response shifts. 
 Multiple factors may contribute to the WOMAC being more influenced by 
response shift than the other PROs evaluated in this study.  The version of the WOMAC 
included in this study consists of 24 items with 5 item Likert-type response choices.  
Response choices include “none”, “mild”, “moderate”, “severe”, or “extreme”.  This type 
of scale can be highly subjective and may be prone to scale recalibration.  Depending on 
the patient’s prior experiences, mild and moderate may have different meanings over time 
as the patient has more information and new experiences for comparison.  While other 
PRO instruments contain some similarly structured questions, the WOMAC provides 
significantly less context from which the patient is asked to answer the questions.  For 
each of the 3 domains of the WOMAC –pain, stiffness, and function – the patient is 
prompted with a simple statement such as “How much pain do you have…” or “What 
degree of difficulty do you have…” followed by a list of activities or tasks such as going 
up and down stairs, sitting or lying, or rising from bed.  These questions do little to frame 
the appraisal process.  In contrast, the IKDC, SF-36, and Lysholm provide a set of 
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parameters from which the patient is asked to evaluate themselves.  They also may be 
provided with more objective criteria for comparative rating.  For example, the SF-36 
instructs patients to answer questions with respect to work or daily activities (a specific 
setting) in the last 4 weeks (a specific time frame) and separates physical health from 
emotional health (a specific aspect of health/function).  Similarly, the IKDC and the 
Lysholm provide the patient with reference criteria creating meaningful standards around 
which he or she can anchor his or her internal scale.  For example, the IKDC asks “What 
is the highest level of activity you are able to perform without significant giving way in 
your knee?” and in addition to providing response choices such as “very strenuous” or 
“strenuous” examples of each level of activity are provided, such as “very strenuous 
activities like jumping or pivoting as in basketball or soccer.”  By placing the dysfunction 
of giving way in the participation context of soccer or basketball the instrument is cueing 
the patient to a specific sample of relevant experiences or activities from which to 
evaluate his or her own function.   Finally, the Lysholm scale may be resistive to response 
shift by providing objective examples of function, such as providing set distances for how 
far a patient is able to walk without knee pain.  The use of reference points for 
comparison may reduce the likelihood of Lysholm scores being subject to scale 
recalibration.  By providing scale anchors and directing the patient towards a specific 
sample of experiences the IKDC, SF-36, and Lysholm appear to reduce the risk of 
significant variation in scale, and conceptualization between and within patients over 
time. 
 The use of scale anchors and direction toward relevant experiences to reduce the 
effect of response shift on PRO scores is consistent with Rapkin and Schwartz’s 
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previously proposed model of self-appraisal for health related quality of life.
139
  
According to this model, when faced with an assessment question a patient completes 
four distinct steps to arrive at a response.  The patient first establishes a frame of reference 
from which to consider the question.  Next, a sample of specific experiences relative to 
that frame of reference is selected.  These sample experiences are then judged against 
subjective standards of comparison, and finally a combinatory algorithm is applied to 
summarize these experiences and select a response.
139
  The first three steps of this process 
present an area in which reconceptualization (change in initial frame of reference), 
reprioritization (change in which experiences are relevant to be sampled), and 
recalibration (change in standards for comparison) may occur resulting in a response shift.  
By providing cues to trigger a frame of reference, referring to specific experiences to 
sample, and/or providing set standards for comparison, PRO instruments may be able to 
effectively reduce the influence of response shift on outcome scores, making comparisons 
of scores across testing points more valid and accurate. 
 The WOMAC demonstrated evidence of an individual level response shift at 6 
months, but not at 12 months.  Performance measures and contextual factors may explain 
these variations in response shift over time.  As discussed in Chapter 3 of this dissertation, 
there were very few differences in functional performance between preoperative and 12 
month postoperative assessments.  Significant changes were only observed for Walk 
Across speed and Step Up/Over lift-up force.  Functional capacity at preoperative and 12 
month time points was similar; the relevance of this finding is that patients are likely 
participating in similar activities at these time points.  Furthermore, many restrictions in 
activity and work have or are being removed from the patient at the 12 month time point, 
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but may still be in place at the 6 month time point.  This is particularly true for those 
patients involved in sports activity or manual labor.  Recent activity participation, or lack 
thereof, has been proposed as a potential factor contributing to response shift.
40
  At the 6 
month time point patients have a sample of work, recreation, and physical therapy 
activities from which to choose when completing the appraisal process.  This sample of 
experiences may be different from those available for appraisal prior to undergoing ACI 
or at the 12 month time point.  The removal of work and physical activity restrictions, 
along with the natural healing process, may result in a very similar sample of experiences 
for appraisal at the preoperative and 12 month time points.  As a result, the patient may 
use a similar frame of reference when completing the PROs at the preoperative and 12 
month postoperative time points, resulting in little to no response shift between these time 
points. 
 Finally, no significant correlation was observed between TC values and RS.  
These results suggest that the occurrence of response shift is not a function of treatment 
success as traditionally evaluated using Pre-Post PRO scores.  These results are similar to 
those of Balain et al. who observed no differences in any response shift variables (pre-
test, then-test, TC, or RSAC scores) between groups of patients with varying levels of 
satisfaction following microfracture.
10
  These observations support the importance of 
personal and environmental factors when considering response shift.  The World Health 
Organization’s International Classification of Functioning, Disability, and Health (ICF) 
seeks to model an individuals’ health based on three principle components: body function 
and structure, activity, and participation.
2
  However, each of these components can be 
influenced by contextual factors which include both personal and environmental factors.
2
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Personal and environmental factors may explain why among cartilage patients response 
shift seems to be an individual and not a group phenomenon.  Unlike a terminal disease, 
which will inevitably impact every aspect of life, the impact of physical limitations 
secondary to knee surgery may vary from person to person depending on factors such as 
employment status, pre-injury activity level, self-image, social support, and preoperative 
expectations.  These contextual factors have previously been referred to as  “antecedents”  
in Spranger and Schwartz’s model of response shift and health related quality of life.
163
  
This model of response shift stresses the importance of variables such as personality, 
sociodemographics, access to care, physical environment, expectations, and spiritual 
identity on health outcomes.  All of these factors may vary from person to person, further 
explaining the great variability in response shift observed and why evidence of a 
significant response shift may exist on an individual level, but not on the group level. 
Limitations 
 The use of the then-test method to evaluate response shift may be considered a 
limitation of this study.  By asking patients to recall their level of function 6 to 12 months 
prior,  this method may be prone to recall bias.
154  However, the then-test method has 
been demonstrated as having convergent validity with more complicated methods of 
evaluating response shift including structural equation modeling and analysis of 
covariance which require much larger samples sizes than were available in this 
investigation.
154, 177
  Additional research has demonstrated that recall bias alone was 
unable to explain changes in then-test scores observed among cancer patients, and at least 
a portion of observed changes could be attributed to response shift via scale 
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recalibration.
157
  Furthermore, use of the then-test method allowed for direct comparison 
to previous investigations of response shift in orthopaedic knee patients. 
 
CONCLUSIONS 
 There was no evidence of a group level effect for response shift following ACI.  
These results support the validity of traditional pre-test/post-test research designs in 
evaluating treatment effects following cartilage repair.  Although some variations may be 
observed between TC and RSAC scores for PROs, on the group level these variations are 
not uniform in direction, do not exceed MDC values, and do not alter the clinical 
interpretation of treatment outcomes.  However, there is evidence that response shifts may 
occur on an individual level on a patient by patient basis, and scores on the WOMAC in 
particular may be influenced by response shifts.  Future research should examine what 
factors may make an individual prone to a response shift and how those factors can be 
utilized to provide the individual with the highest possible self-perceived health related 
quality of life.  On a clinical level recognizing the occurrence of a response shift may be 
key in evaluating treatment progress for individual patients.  This is particularly true for 
treatments such as ACI where physicians depend heavily on patient self-report and 
appraisal of progress because tools for diagnostic evaluation are limited and not always 
feasible or cost-effective.   
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CHAPTER 5: FUNCTIONAL OUTCOMES FOLLOWING ARTICULAR 
CARTILAGE IMPLANTATION: BALANCING PATIENT ORIENTED AND 
PERFORMANCE BASED MEASURES 
 
PURPOSE AND AIMS 
The purposes of the presented studies were to investigate clinical and functional 
outcomes following autologous chondrocyte implantation (ACI) to the knee and the 
methodology for documenting those outcomes.  Specifically, the following aims and 
hypotheses were examined within this dissertation: 
1. To systematically review and evaluate the responsiveness of common 
instruments used to measure PROs following ACI at varying time points.  
Hypotheses:  All instruments will demonstrate improved self-reported function 
and health related quality of life following ACI with the simplest instruments 
showing the greatest treatment effect. 
2. To determine among articular cartilage patients the reliability of the following 
NeuroCom Balance Master
®
 long force plate assessments:  Walk Across, 
Weight Bearing Squat, Unilateral Stance, Sit-to-Stand, Step Up/Over, and 
Forward Lunge tests.  Hypotheses:  The reliability of all measures of time, 
distance, and force will demonstrate acceptable ICC values>0.75.  There will 
be poor reliability of measures of sway and balance with ICC values <0.75. 
3. To document the clinical outcomes of ACI patients over one year following 
surgery utilizing both patient reported outcomes (PROs) and performance 
based assessments (PBAs), and to examine the relationship between PROs and 
PBAs.  Hypotheses: All PROs and PBAs will demonstrate an initial decrease 
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in function at the three month time point.  There will be improved function at 6 
months and improvements from baseline at the 12 month time point based on 
PRO and PBA evaluations.    
4. To determine if patients undergoing ACI experience a response shift between 
preoperative assessment and evaluation at 6 and 12 months postoperative.  
Hypotheses: There will be evidence of a response shift as assessed via PROs.  
Further evidence of this response shift will be supported by changes in the 
relationship between PROs and PBAs over time.  
 
SUMMARY 
Responsiveness of Patient Reported Outcomes (PROs) 
 In Chapter 1 the large body of work regarding the use of PROs following ACI was 
reviewed.  Overall the evidence supporting the use of ACI for the treatment of cartilage 
defects is of poor to moderate methodological quality with included studies observed to 
have a mean modified Coleman Methodology score
87
 of 50.9 ± 9.2.  Additionally, the 
majority of studies were Level 2b prospective cohorts with only 4 Level 1b randomized 
controlled trials meeting the inclusion and exclusion criteria.
4
  Despite these limitations in 
methodological quality and inconsistent reporting of outcome means and measures of 
variability, a grade B
4
 recommendation was made for the use of the Medical Outcomes 
Study 36-Item Short Form Health Survey Physical Component Scale (SF-36 PCS),
105, 106, 
179
  the International Knee Documentation Committee Subjective Knee Form (IKDC),
77
 
the Lysholm Knee Scale (Lysholm),
96, 168
  the modified Cincinnati Knee Rating System 
(MCKRS),
31
 the Western Ontario and McMaster Universities Osteoarthritis Index 
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(WOMAC),
18, 19
 and the Knee Injury and Osteoarthritis Outcome Score (KOOS)
148
 as 
outcome measures following ACI.  
 To determine which PROs may be most receptive to changes in self-reported 
function following ACI meta-analyses were conducted to examine the responsiveness of 
each instrument using Hedge’s g effect sizes over 4 postoperative time points with follow-
up ranging from less than 1 year to 4 or more years after ACI.  Across all time points the 
hypothesis was supported with the IKDC, KOOS, Lysholm, MCKRS, and SF-36 PCS all 
demonstrating large effect sizes and significant improvement in self-reported function and 
health related quality of life following ACI.  There was not sufficient data to analyze the 
WOMAC at any of the individual time points and limited data for the SF-36 PCS and the 
MCKRS.  The Lysholm was highly responsive as early as less than 1 year following ACI 
and was consistently responsive throughout postoperative follow-up.  However, this 
instrument may not be responsive to changes in function associated with the resumption 
of higher demand activities such as sports which occurs after the 1 year time point.  For 
the evaluation of long-term outcomes among patients who intend to return to physical 
activity, this review supports the use of the IKDC which was able to detect increasing 
treatment effects over time.  The KOOS-sports and recreation subscale also demonstrated 
increasing treatment effects over time; however, the IKDC was significantly more 
responsive than this KOOS-subscale at time point II (between 1 and < 2 years post ACI) 
and at time point IV (> 4 years post ACI).  The use of the Lysholm and IKDC together 
represents a responsive combination of PRO instruments that are able to efficiently 
document both short-term and long-term treatment effects among patients of a variety of 
activity levels following ACI. 
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Reliability of Performance Based Assessments (PBAs) 
 The use of PBAs following ACI has been limited, with only a few authors 
reporting functional performance for the 6 minute walk-test, the single-leg hop, and 
isokinetic strength measures. 
44, 45, 146, 172
  In this investigation, tasks that are part of the 
NeuroCom Balance Master
®
 long force plate (LFP) (NeuroCom International, Clackamas, 
OR) testing protocol were evaluated for their reliability.  The examined tasks included the 
Unilateral Stance, Weight Bearing Squat, Sit-to-Stand, Rhythmic Weight Shift, Step-
Up/Over, and the Forward Lunge. 
3
  These outcome measures are of low to moderate 
demand, simulate activities of daily living, and are feasible for performance by ACI 
patients throughout much of the recovery process.  Because PBA measures should at a 
minimum have the potential to be evaluated pre-operatively and at long-term (>1 year) 
follow-up, a cross-sectional sample of ACI patients at the preoperative and 1 year 
postoperative time point were enrolled in this study.  Intraclass correlations (ICC(2,1)) 
were used to evaluate the test re-test reliability of each outcome measure.  For unilateral 
tests, only the reliability of the involved (surgical) limb was analyzed. All tests with ICC 
greater than or equal to 0.75 were considered to have acceptable reliability as a PBA for 
documenting outcomes following ACI.  
 Overall reliability varied by task, yet at least one variable for each task 
demonstrated acceptable test-retest reliability.  As hypothesized - force, time, and distance 
measures were reliable for the Weight Bearing Squat at 90⁰, Step-Up/Over, and Lunge 
with ICC values ranging from .75 to .93.  Similarly, Walk Across length and speed were 
also reliable; however, Walk Across width was not, nor was the Weight Bearing Squat at 
0⁰, 30⁰ or, 60⁰ or Sit-to-Stand rise time or center of gravity sway velocity.  Contrary to the 
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hypothesis for balance measures, the Unilateral Stance demonstrated acceptable reliability 
in both the eyes open (ICC = 0.75) and eyes closed (ICC = 0.77) conditions.  Overall, the 
selected tasks, particularly the Step Up/Over and Forward Lunge, demonstrated reliability 
across a variety of levels of function among both preoperative patients and those one year 
post ACI surgery.   Furthermore, this study provided minimal detectable change values 
(MDC) for LFP variables to evaluate longitudinal changes in function following ACI. 
Application of PROs and PBAs to Evaluate Changes in Patient Function Following 
ACI 
 As previously discussed, few studies have utilized PBAs to document the return of 
function following ACI.
44, 45, 146, 172
  No known studies have examined the timeline for 
return to function following ACI using low to moderate demand PBAs that recreate the 
demands and stresses of common activities of daily living such as squatting, rising from 
sitting, or going up and down stairs, in addition to walking.  Nor has the relationship 
between PROs and PBAs been examined in an ACI patient population.  The purpose of 
this study was to provide an accurate description of functional recovery during the first 
year following ACI for patients, physicians and rehabilitation specialists.  Furthermore, an 
understanding of the relationship between PROs and PBAs provides important 
information regarding the importance of collecting varying types of outcomes in future 
cartilage repair research.   
 It was observed that patients reported significant improvements in self-reported 
function on the IKDC, Lysholm, and SF-36 PCS as early as 6 months and on the 
WOMAC at 12 months following ACI.  However, there was an initial decrease in 
function at the 3 month time point for several of the PBAs with asymmetrical weight 
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distribution during squatting and increased performance time for lunging and stepping up 
and over a box.  At the 6 month time point performance deficits still remained, such as 
asymmetrical weight distribution during squatting, but small improvements were 
observed for Walk Across stride length.  At the 12 month time point the only performance 
variables to demonstrate changes from the preoperative time point were Walk Across 
speed and stride length, and Step Up/Over lift-up index.  These results support existing 
theory that although improvements in self-report measures may occur early 
postoperatively, maximal defect healing and functional improvement continues beyond 12 
months following ACI. 
22, 90, 145
 
 Although low to moderate correlations were observed between various PROs and 
PBAs at each of the 4 time points, no consistent correlations were observed between any 
of the PROs and PBAs across all four time points.  This inconsistent to non-existent 
relationship between PROs and PBAs is consistent with previous literature concerning 
orthopedic knee patients.
52, 79, 82, 117, 120, 144, 159
  The occurrence of changes in self-report 
measures of function prior to changes in performance based measures of function may be 
a result of the large influence pain levels have been observed to have on PRO scores.
79, 97, 
165, 166
  The lack of consistent correlations between PROs and PBAs, and the observed 
improvement in PRO scores in the absence of improved physical performance supports 
the importance of incorporating both types of outcome measures when documenting 
patient outcomes.  The importance of a patient’s own rating of function and subjective 
feelings towards joint health cannot be ignored.  However, when considering decisions 
such as ability to return to work or physical activity, or to evaluate postoperative changes 
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in biomechanics, performance based measures provide unique information that cannot be 
fully and accurately captured by PROs along. 
The Influence of Response Shift on Patient Reported Outcomes following ACI 
 The final question of this dissertation examined the phenomenon of response shift 
among ACI patients when evaluating outcomes using the IKDC, Lysholm, SF-36 PCS, 
and KOOS.  Response shift is the changing of an individual’s frame of reference or 
perspective due to reprioritization, recalibration, or reconceptualization.
163
   If response 
shift is occurring it may not be appropriate to compare PRO scores across time as a 
different set of standards and a changing appraisal process is used to respond to questions 
at each time point.  A group level effect for response shift has the potential to result in 
under or over reporting of treatment effects.  On an individual level, the identification of a 
response shift may be relevant to clinical care, particularly for therapies such as ACI 
where self-report of changes in symptoms and pain are the primary measure of treatment 
success. 
  Among ACI patients there was no evidence to support the hypothesis that a group 
level effect for response shift would be evident in the included PROs.  These results 
support the validity of traditional pre-test/post-test research designs for evaluating 
treatment effects following cartilage repair on the group level.  However, an individual 
level response shift was observed for the WOMAC at 6 months post-ACI.  Response shift 
magnitude values for the WOMAC at 6 months were significantly different from 
previously identified MDC values.  The WOMAC may be more prone to a response shift 
than other PRO instruments due to its dependence on Likert–type response scales and the 
failure to reference specific locations, times, or criteria that provide the patient with a 
 
 
109 
 
context from which to rate his or her function.  These results demonstrate that although, a 
measurable response shift does not occur in a uniform direction following ACI, it does 
occur on a patient-by-patient basis with some patients over-estimating their preoperative 
level of function and other patients under-estimating their preoperative function.  
 
SYNTHESIS OF RESULTS AND CONCLUSIONS 
 The overall purpose of this dissertation was to describe functional outcomes 
following ACI and to examine the use of PROs and PBAs for evaluating functional 
outcomes following ACI.  From this investigation several observations and 
recommendations for outcomes assessment following ACI can be made. 
1. The Lysholm and the IKDC are the recommended PRO instruments for evaluating 
changes in self-reported function following ACI.  Both instruments exhibit 
excellent responsiveness to functional changes following ACI with the Lysholm 
being most responsive to short-term changes in lower level activities such, as 
walking, going up and down stairs, or squatting.  The IKDC demonstrated 
increasing responsiveness over time as patients become eligible to return to higher 
demand activities such as running or cutting.  Furthermore, neither instrument was 
influenced by response shift on either the group or individual level.  As a result 
these scores can be used for the traditional pre/post evaluation of function on a 
group level, or can be used to monitor changes on a patient by patient basis. 
2. Patients and clinicians can realistically anticipate significant improvements in self-
reported function as early as 6 months following ACI.  However, some 
postoperative loss of function is likely to be present at the 3 and 6 month time 
 
 
110 
 
points for movements such as stepping, lunging, and squatting.  At 6 and 12 
months, improvements in walking stride length can be expected, but side to side 
discrepancies in performance for some activities may linger due to learned habits 
or continued weakness.   
3. Both PROs and PBAs are needed to create a complete picture of assessment.  The 
relationship between PROs and PBAs was inconsistent and varied across time.  
Significant improvements in PROs were observed in the absence of substantial 
changes in physical performance.  PROs may be overly influenced by changes in 
pain levels resulting in a poor correlation with direct physical performance, even 
when instrument content addresses those tasks being performed.   
4. Response shift does not substantially influence the interpretation of treatment 
outcomes when using the IKDC, Lysholm or SF-36 PCS.  Response shift may 
influence outcomes when using the WOMAC on an individual patient level.  
Although, no group effects were observed for response shift, individual patients 
may experience a response shift and this potential for response shift further 
supports the use of valid and reliable PBAs as an additional outcome measure 
following ACI. 
 
FUTURE RESEARCH 
 In this dissertation the responsiveness of several PROs was reviewed and the 
reliability of a series of force plate based PBAs was established.  A time line for recovery 
of function following ACI using both PROs and PBAs was presented.  Future research 
should continue to examine the influence of factors such as defect location, defect size, 
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concomitant procedures, and rehabilitation parameters (such as time non-weight bearing, 
use of continuous passive motion, and intensity of strengthening activities) on both PRO 
and PBA outcomes.  Additionally, longer follow-up is necessary to determine if PBAs 
that failed to demonstrate improvement at the 12 month time point subsequently improve 
as the patient is cleared for return to regular sports and physical activity.  Finally, the 
relationship between preoperative or early postoperative PRO and PBA scores and long-
term treatment success should be investigated to help in the selection of patients most 
likely to succeed and to recognize early clinical failures and provide them with alternative 
treatments. 
 While a significant or meaningful group level effect for response shift was not 
observed in this study, a subset of patients was observed to experience response shift at 
the individual level across multiple PRO instruments.  This subset warrants further 
considerations as response shift can be a beneficial coping mechanism in response to 
disease or disability,
33, 163
 or it may negatively impact a person’s health related quality of 
life in the event that his or her perceived expectations of treatment or self-evaluation of 
function are not realistic.
72
  Further understanding and identification of patients prone to 
response shift may improve outcomes assessment and assist in the improvement of patient 
health related quality of life of patient by patient basis.  
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APPENDICES  
APENDIX A – PATIENT REPORTED OUTCOME INSTRUMENTS 
*These pages are meant to serve as a representation of instrument content and are 
formatted to fit page requirements not to serve as the actual instruments themselves. 
International Knee Documentation Committee Subjective Knee Form (IKDC) 
*Grade symptoms at the highest activity level at which you think you could function without significant symptoms, even 
if you are not actually performing activities at this level. 
1. What is the highest level of activity that you can perform without significant knee pain? 
Very strenuous activities like jumping or pivoting as in basketball or soccer 
Strenuous activities like heavy physical work, skiing or tennis 
Moderate activities like moderate physical work, running or jogging 
Light activities like walking, housework or yard work 
Unable to perform any of the above activities due to knee pain 
 
2. During the past 4 weeks, or since your injury, how often have you had pain? 
Never 0 1 2 3 4 5 6 7 8 9 10 Constant 
 
           
 
 
3. If you have pain, how severe is it? 
No pain 0 1 2 3 4 5 6 7 8 9 10 Worst Pain 
Imaginable 
 
           
 
 
4. During the past 4 weeks, or since your injury, how stiff or swollen was your knee? 
Not at all Mildly Moderately Very  Extremely 
 
5. What is the highest level of activity you can perform without significant swelling in your knee? 
Very strenuous activities like jumping or pivoting as in basketball or soccer 
Strenuous activities like heavy physical work, skiing or tennis 
Moderate activities like moderate physical work, running or jogging 
Light activities like walking, housework, or yard work 
Unable to perform any of the above activities due to knee swelling 
 
6. During the past 4 weeks, or since your injury, did your knee lock or catch? 
Yes   No 
 
7. What is the highest level of activity you can perform without significant giving way in your knee? 
Very strenuous activities like jumping or pivoting as in basketball or soccer 
Strenuous activities like heavy physical work, skiing or tennis 
Moderate activities like moderate physical work, running or jogging 
Light activities like walking, housework or yard work 
Unable to perform any of the above activities due to giving way of the knee 
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IKDC Continued. 
SPORTS ACTIVITIES: 
 
8. What is the highest level of activity you can participate in on a regular basis? 
Very strenuous activities like jumping or pivoting as in basketball or soccer 
Strenuous activities like heavy physical work, skiing or tennis 
Moderate activities like moderate physical work, running or jogging 
Light activities like walking, housework or yard work 
Unable to perform any of the above activities due to knee 
 
9. How does your knee affect your ability to: 
  
Not difficult 
at all 
Minimally 
difficult 
Moderately 
Difficult 
Extremely 
difficult 
Unable 
to do 
a. Go up stairs      
b. Go down stairs      
c. 
Kneel on the front of your 
knee 
     
d. Squat      
e. Sit with your knee bent      
f. Rise from a chair      
g. Run straight ahead      
h. 
Jump and land on your 
involved leg 
     
i. Stop and start quickly      
 
FUNCTION: 
10. How would you rate the function of your knee on a scale of 0 to 10 with 10 being normal, excellent function and 0 
being the inability to perform any of your usual daily activities which may include sports? 
 
FUNCTION PRIOR TO YOUR KNEE INJURY: 
Cannot perform 
daily activities  
 
0 1 2 3 4 5 6 7 8 9 10 No limitation 
           
 
 
CURRENT FUNCTION OF YOUR KNEE: 
Cannot perform 
daily activities 
 
0 1 2 3 4 5 6 7 8 9 10 No limitation 
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 Lysholm Knee Scale  
 
 
 
1. Do you have a limp?  
No 
Slight limp or limp periodically  
Severe limp and constantly     
 
2. What support do you need for walking?  
None  
Stick or crutch  
I am unable to weight bear. 
 
3. Does your knee lock?  
No locking or catching sensations  
Catching sensation but no locking 
Locking – occasionally  
 Locking – frequently 
Locked joint on examination (it is locked now)  
 
4. How unstable is your Knee?  
It never gives way  
Rarely during athletics or other severe 
exertion  
Frequently during athletics 
Occasionally during daily activities 
Often during daily activities 
Every step 
 
 
5. How painful is your Knee?  
    No pain 
Inconstant and slight during severe exertion 
Marked during severe exertion 
Marked on or after walking 2km 
 Marked on or after walking less than 2km 
 Constant 
 
6. Do you have swelling in your knee?  
None 
On severe exertion 
On ordinary exertion  
Constant  
 
7. Can you climb stairs?  
No problems 
Slightly impaired 
One step at a time 
Impossible  
 
8. Can you squat?  
No problems 
Slightly impaired 
Not beyond 90 degrees 
Impossibl
 
 
115 
 
Medical Outcomes Study 36-Item Short Form Health Survey (SF-36) 
 
1. In general, would you say your health is: 
Excellent 
Very Good 
Good  
Fair 
Poor 
 
2. Compared to one year ago, how would you rate your health in general now? 
Much better now than 1 year ago 
Somewhat better now than 1 year ago 
About the same as 1 year ago 
Somewhat worse now than 1 year ago 
Much worse now than 1 year ago 
 
3. The following questions are about activities you might do during a typical day. Does your health now limit you in 
these activities? 
If so, how much? 
  Yes, limited 
a lot 
Yes, limited 
a little 
No, not limited at 
all 
a.  Vigorous activities, such as running, lifting heavy 
objects, participating in strenuous sports  
   
b.  Moderate activities, such as moving a table, pushing a 
vacuum cleaner, bowling, or playing golf  
   
c.  Lifting or carrying groceries     
d.  Climbing several flights of stairs     
e.  Climbing one flight of stairs     
f.  Bending, kneeling or stooping     
g.  Walking more than a mile     
h.  Walking several hundred yards     
i.  Walking one hundred yards     
j.  Bathing or dressing yourself     
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SF-36 Continued 
4. During the past 4 weeks, how much of the time have you had any of the following problems with your work or other 
regular daily activities as a result of your physical health? 
 All of the 
time 
Most of    
the time 
Some of 
the time 
A little of  
the time 
None of   
the time 
a. Cut down on the amount of time you spent on   
work or other activities 
     
b. Accomplished less than you would like      
c. Were limited in the kind of work or other   
activities 
     
d. Had difficulty performing the work or other 
activities (for example, it took extra effort) 
     
 
5. During the past 4 weeks, how much of the time have you had any of the following problems with your work or other 
regular daily activities as a result of any emotional problems (such as feeling depressed or anxious)? 
 All of the 
time 
Most of    
the time 
Some of 
the time 
A little of 
the time 
None of 
the time 
a. Cut down on the amount of time you spent on   
work or other activities 
     
b. Accomplished less than you would like       
c. Did work or other activities less carefully than usual      
 
6. During the past 4 weeks, to what extent has your physical health or emotional problems interfered with your normal 
social activities with family, friends, neighbours, or groups? 
Not At All 
Slightly 
Moderately 
Quite a Bit 
Extremely 
 
7. How much bodily pain have you had during the past 4 weeks? 
None 
Very Mild 
Mild 
Moderate 
Severe 
Very Severe 
 
8. During the past 4 weeks, how much did pain interfere with your normal work (including both work outside the home and 
housework)? 
Not at All 
A Little Bit 
Moderately 
Quite a Bit 
Extremely 
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SF-36 Continued 
9. These questions are about how you feel and how things have been with you during the past 4 weeks. For each question, 
please give the one answer that comes closest to the way you have been feeling. How much of the time during the past 4 
weeks… 
 All of the 
time 
Most of    
the time 
Some of    
the time 
A little of  
the time 
None of 
the time 
a. Did you feel full of life?       
b. Have you been very nervous?       
c. Have you felt so down in the dumps that nothing  
could cheer you up? 
     
d. Have you felt calm and peaceful?       
e. Did you have a lot of energy?       
f. Have you felt downhearted and depressed?       
g. Did you feel worn out?       
h. Have you been happy?       
i. Did you feel tired?       
 
10.During the past 4 weeks, how much of the time has your physical health or emotional problems interfered with your 
social activities (like visiting with friends, relatives, etc.)? 
All of the time 
Most of the time 
Some of the time 
A little of the time 
None of the time 
 
11. How TRUE or FALSE is each of the following statements for you? 
  Definitely 
True 
Mostly   
True 
Don’t 
Know 
Mostly 
False 
Definitely 
False 
a.  I seem to get sick a little easier than other 
people  
     
b.  I am as healthy as anybody I know       
c.  I expect my health to get worse       
d.  My health is excellent       
 
 
 
 
 
. 
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Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) 
P: These questions concern the amount of pain you are currently experiencing due to arthritis in your hips 
and your knees. For each situation, please enter the amount of pain you have recently experienced. How 
much pain do you have... 
1. Walking on a flat surface  None Mild Moderate Severe Extreme 
2. Going up or down stairs  None Mild Moderate Severe Extreme 
3. At night while in bed  None Mild Moderate Severe Extreme 
4. Sitting or lying  None Mild Moderate Severe Extreme 
5. Standing upright  None Mild Moderate Severe Extreme 
 
M: These questions concern the amount of joint stiffness (not pain) you are currently experiencing due to arthritis in 
your hips and or knees. Stiffness is sensation of restriction or slowness in the area around which you move your joints. 
6. How severe is your stiffness after 
first waking in the morning? None Mild Moderate Severe Extreme 
7. How severe is your stiffness after sitting, 
lying or resting later in the day? None Mild Moderate Severe Extreme 
 
F: These questions concern your physical function. By this we mean your ability to move around and to look after 
yourself. For each of the following activities please indicate the degree of difficulty you are experiencing due to 
arthritis. What degree of difficulty do you have with... 
8. Descending stairs None Mild Moderate Severe Extreme 
9. Ascending stairs None Mild Moderate Severe Extreme 
10. Rising from sitting None Mild Moderate Severe Extreme 
11. Standing None Mild Moderate Severe Extreme 
12. Bending to floor None Mild Moderate Severe Extreme 
13. Walking on flat None Mild Moderate Severe Extreme 
14. Getting in/out of car None Mild Moderate Severe Extreme 
15. Going shopping None Mild Moderate Severe Extreme 
16. Putting on socks/stockings None Mild Moderate Severe Extreme 
17. Rising from bed None Mild Moderate Severe Extreme 
18. Taking off socks/stockings None Mild Moderate Severe Extreme 
19. Lying in bed None Mild Moderate Severe Extreme 
20. Getting in/out bath None Mild Moderate Severe Extreme 
21. Sitting None Mild Moderate Severe Extreme 
22. Getting on/off toilet None Mild Moderate Severe Extreme 
23. Heavy domestic duties None Mild Moderate Severe Extreme 
24. Light domestic duties None Mild Moderate Severe Extreme 
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APPENDIX B: PROPOSED METHOD FOR VERIFYING RESPONSE SHIFT 
WITH PERFORMANCE BASED ASSESSMENTS 
 In the event a group level response shift had occurred a series of linear regression 
analyses would have been conducted to determine if the occurrence of the response shift 
could be validated by changes in the relationship between pre-test scores and preoperative 
PBAs, then-test scores and preoperative PBAs, and post-test scores and postoperative 
PBAs.  The purpose of this appendix is to provide an example of how this proposed 
method of evaluating response shift would have been performed had there been evidence 
of a response shift.    
 A significant correlation was observed between pre-test IKDC score and 
preoperative Walk Across length (R = 0.43, p = 0.024) and between then-test at 6 months 
IKDC score and preoperative Walk Across length(R = 0.43, p= 0.04).  The correlation 
between IKDC post-test score at 6 months and Walk Across length at 6 months was not 
significant (R = 0.06, p = 0.81).  Because the then-test at 6 months and post-test at 6 
months were completed at the same time it was theorized that both tests would be 
completed from the same frame of reference.  If a response shift had occurred the 
relationship between the then-test score at 6 months and preoperative Walk Across length 
and the relationship between the post-test score at 6 months and 6 month Walk Across 
length would be similar.  However, the relationship between pre-test score and pre-test 
Walk Across length would be significantly different.  To evaluate these relationships a 
series of regression equations were employed (Table 4.1).   
 The regression model for preoperative Walk Across length as a function of pre-
test IKDC was preoperative Walk Across length = 0.295 +.003(pre-test IKDC Score) 
(Adjusted R
2
 = 0.15).  The 95% confidence interval for the intercept was 0.199 to 0.390, 
 
 
120 
 
while the confidence interval for the parameter estimate for IKDC score was 0.000 to 
0.005.  The regression model for preoperative Walk Across length as a function of 6 
month then-test IKDC score was preoperative Walk Across length = 0.335 +.002(then-
test 6month IKDC Score) (Adjusted R
2
 = 0.15).  The 95% confidence interval for the 
intercept was 0.261 to 0.410, while the confidence interval for the parameter estimate for 
IKDC score was 0.000 to 0.004.  Given that the 95% confidence intervals for both the 
intercept and the parameter estimates overlap, these observations do not support the 
occurrence of a response shift resulting in a change in patient frame of reference between 
the preoperative and 6 month time points.  These results are in agreement with the group 
level analysis that failed to identify a response shift for the IKDC or any other PRO 
instruments and fail to support the hypothesis that  βPre ≠ βthen  where βPre  is the parameter 
estimate for pre-test IKDC score and  βthen is the parameter estimate for then test IKDC 
score at 6 months. 
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